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ABSTRACT 
INTRODUCTION 
Sexually Transmitted Infections cause significant morbidity and mortality. 
Genital Human papilloma virus infection is the most common sexually transmitted 
infection in the world with an estimated worldwide prevalence of 9 to 13% and 
approximately 6 million people being infected each year. 
AIMS AND OBJECTIVES 
The aim of this study is to Determine the prevalence of human papilloma virus 
infection found in high risk subjects like Female sex workers, Men having sex with 
men practicing commercial sex, Promiscuous men, Promiscuous women and 
transgenders practicing commercial sex attending STD clinic in our hospital and to 
identify concomitant sexually transmitted infections in the study group and emphasize 
on the need of vaccination against HPV in these high risk groups. 
MATERIALS AND METHODS 
200 high risk subjects attending STD Clinic our hospital were included in the 
study. HPV-PCR for HPV 16 and 18 and presence of other STIs were studied and 
results were observed. 
RESULTS 
Out of 200 subjects in this prospective study, Promiscuous men and Female sex 
workers form the majority. The common age group was  31- 40 years. Most of the 
subjects were married (71%) except MSM and Transgender population. The mode of 
sex among the study group was heterosexual (81.5%). Among the men having sex 
with men, the common type of sex was oro ano receptive (26.6%) kothis, followed by 
ano receptive (20%). The last sexual contact was protected in 52.5% of the subjects. 
62.5% of the subjects had only primary level of education. Concomitant sexually 
transmitted illnesses were present in 25% (50 out of 200) subjects. Candidiasis was 
found in13, Bacterial vaginosis in 12, Syphilitic ulcer in 10, Gonorrhoea in 5, Genital 
warts in 5 and Trichomoniasis in 3 and Herpetic ulcer in 2 of the 50 subjects positive 
for other STIs. In serological evaluation, HIV was reactive in 14, RPR in 20 and 
TPHA in 15 subjects. HPV 16 and 18 was positive in 8 subjects by PCR. HPV 16 was 
positive in 5, HPV 18 in 2 and HPV 16 and 18 in 1 subject. Coinfection in HPV 
positive subjects with other STIs was present in 5 subjects (Bacterial vaginosis in 2, 
Candidiasis in2 and Trichomoniasis in 1 out of the 8 HPV positives). Coinfection of 
HPV 16 and 18 was observed in 1 subject in1, HPV 16 and HIV in 1 and HIV and 
syphilis in 4 subjects. Blood transfusion and IV drug abuse was observed in 2 and 4 
subjects respectively. No HPV positives were found in this group. 
CONCLUSION  
The HPV 16 & 18 PCR analysis of 200 anogenital and pharyngeal swabs 
detected 8 HPV positives which included 5 HPV16, 2 HPV18 and 1 HPV 16 & 18. 
Candidiasis was found in 13(26%),  Bacterial vaginosis in 12 (24%), Syphilitic ulcer 
in 10 (20%), Gonorrhoea in 5 (10%), Genital warts in 5(10%) and Trichomoniasis in 3 
(6%),  Herpetic ulcer in 2 (4%) of the 50 positive for other STIs. High risk HPV 16 
and 18 serotypes are associated with anogenital and head and neck cancers. HPV 
vaccine induces a protective host immune response which is stronger and long lasting 
and includes partial cross protection against non vaccine related serotypes. Education 
about safer sexual practices, regular screening for Sexually transmitted infections and 
prophylactic HPV vaccination in this high risk groups will protect the individuals and 
also prevent the transmission of infection to the general population. 
KEYWORDS 
FSW – Female sex worker MSM – Male having sex with male, TG – Trans 
Gender, HPV – Human Papilloma Virus, PCR – Polymerase Chain Reaction. 
 
 
  
 
INTRODUCTION 
 Sexually Transmitted Infections cause significant morbidity and 
mortality. Genital Human papilloma virus infection is the most common 
sexually transmitted infection in the world with an estimated worldwide 
prevalence of 9 to 13% and approximately 6 million people being infected each 
year. Human papilloma virus infections are mostly acquired during adolescence 
or in early adulthood1. HPV infections are either asymptomatic and do not not 
cause clinical disease or may persist clinically as anogenital warts and may 
progress to precancerous lesions and cancers of the cervix, vulva, vagina, 
penis, anus and oropharynx. HPV, a non enveloped DNA virus is a member of 
Papillomaviridae family of viruses. More than 100 HPV genotypes are known 
of which approximately 40 types infect the anogenital region and around 13 are 
considered high risk associated with malignancy. Low risk HPV types 6 and 11 
cause 90% of anogenital warts. The high risk type 16&18 are known to cause 
about 70% of invasive cervical cancers and 70% of anogenital cancers in 
women and 70% of anal cancers in men. HPV types 6&11 are responsible for 
90% of genital warts and 90% of recurrent respiratory papillomatosis in both 
women and men. HPV types 16&18 are also responsible for 40% of vulvar, 
vaginal and penile cancers and 12% of anal and pharyngeal cancers. 
Approximately 250 million women worldwide are HPV DNA carriers. 
Female sex workers have overall high prevalence of HPV infections of high 
  
risk type2.. Studies have indicated that having multiple sex partners may lead to 
higher HPV transmission. Female sex workers[FSW] are thought to be at 
higher risk of cervical cancer because of high HPV exposure. In addition HPV 
can be transmitted from female sex workers to the general population through 
clients thereby increasing the prevalence of the virus. The most highly 
prevalent HPV types among FSW are HPV 16 [38.9%], HPV 52 [32.7%], HPV 
31 [28.4%], HPV 58 [26%], HPV 51 [25%], HPV 33 [25%] and HPV 6 
[11.5%] . Infection with multiple and high risk HPV types are common among 
Female Sex Workers. The overall prevalence is 48.9%, prevalence of high risk 
types is 43% and low risk type is 24.6%3. Infection rate is higher among 
younger women involved in sexual work for less than one year. HPV 
prevalence is declining among sex workers with increasing age due to immune 
response acquired overtime despite continuing high sexual activity4. 
The median overall prevalence of HPV among HIV positive FSW is 
73.3% and the most highly prevalent HPV types among HIV positive FSW are 
HPV 16 [54.2%] and HPV 18 [21.4%]2. Knowledge of the prevalent HPV 
types in FSW’s may lead to improved prevention measures and assist in 
understanding vaccination in high risk groups. 
The prevalence of Human papilloma virus infection is high among 
sexually active MSM [male having sex with male] with the anal canal being the 
most common site of infection. Although many HPV infection in men have 
been shown to be transient in nature a small percentage persist and can 
  
progress to genital warts, preneoplastic and malignant lesions of the anus, penis 
and oropharynx and recurrent respiratory papillomatosis5. Certain at risk 
groups such as MSM particularly those with HIV infection are 
disproportionately affected. The prevalence of HPV is high among 
transgenders. The high HPV prevalence, the coinfection with multiple 
genotypes and the high frequency of high risk genotypes detected, together 
with a extreme situation of marginalization ,discrimination and stigmatization 
make this population to be of extreme vulnerability6.  Human papilloma virus 
is one of the most common sexually transmitted infection worldwide and it 
causes morbidity and mortality in both men and women via cervical cancer, 
penile cancer, anal cancer, oropharyngeal cancer and genital warts. While 
much of the emphasis in the literature has focused on women and link between 
HPV and cervical cancer, evidence is mounting regarding the high prevalence 
of HPV infection in males particularly in anogenital sites especially in men 
who have sex with men [MSM]. 
HPV is linked to oral, anal and penile neoplasms and also has been 
associated with acquistion of HIV in MSM. Unfortunately there is little public 
awareness about the HPV infection and perhaps less so in high risk 
groups.[FSW,MSM,TG].These high risk groups should be appropriately 
informed about the social and psychological implications of HPV including its 
negative impact on quality of life ,mental well being and sexual practices7.  
  
The purpose of this study is to determine the prevalence of human 
papilloma virus infection and other sexually transmitted infections found in 
high risk subjects attending our hospital and emphasize on the need of 
vaccination against HPV in these high risk groups as a part of coordinated 
strategy to prevent cervical cancer and other HPV related diseases. Biological 
susceptibility to High risk –HPV acquisition and reduced immune competence 
for clearance of HR –HPV infection could result from common treatable 
vaginal infections that disrupt the intricately balanced vaginal ecosystem and 
its innate protective mechanisms against infection and disease8. Hence the 
identification of concomitant sexually transmitted infections is also done as a 
part of this study. 
 
 
 
 
 
 
 
 
 
 
  
                   
AIMS AND OBJECTIVES 
The aim of this study is to  
1. Determine the prevalence of human papilloma virus infection found in 
high risk subjects like Female sex workers, Men having sex with men 
practicing commercial sex, Promiscuous men, Promiscuous women and 
transgenders practicing commercial sex attending STD clinic in our 
hospital. 
 
2. To identify concomitant sexually transmitted infections in the study 
group. 
  
3. Emphasize on the need of vaccination against HPV in these high risk 
groups as a part of coordinated strategy to prevent cervical cancer and 
other HPV related diseases. 
 
 
 
  
 
REVIEW OF LITERATURE 
I. GENERAL PROPERTIES OF HUMAN PAPILLOMA VIRUS 9 
 The Papilloma viruses are a group of non-enveloped, epitheliotrophic 
DNA viruses that cause benign lesions of the skin and mucous membrane (wart 
and condylomas). Papilloma viruses have also been implicated in the 
development of malignancies of epithelial origin like cancer of the uterine 
cervix and tumours of the urogenital tract.  
 The Papillomaviridae family is very large and is currently divided into 
16 genera of which five infect humans (Alpha – Beta- Gamma- Mupa, and 
Nupa papilloma virus). The Papilloma viruses are 55 nm in diameter and 
contain a larger genome (8 kbp).10 
 The HPV of greatest medical importance are members of the alpha 
genus. Beta and gamma species can be commensals  as they are frequently 
isolated from normal skin. The papilloma virus of delta genus are the bovine 
and ungulate types.  
II. VIRION STRUCTURE 9 
 Papilloma viruses are small, non enveloped Icasohedral DNA viruses. 
They replicate in the nucleus of squamous epithelial cells. The papilloma virus 
  
particles have a sedimentation coefficient of 300. The virion particles consist of 
a single molecule of double stranded circular DNA approx. 8000 base pairs 
(bp) in size contained within a spherical protein coat or capsid composed of 72 
capsomeres. The DNA makes up approximately 12% of the virion by weight. 
The virus particles have a density in cesium chloride of 1.34 g/ml. The PV 
capsid consists of two structural proteins. The major capsid protein (L1) has a 
molecular weight of approximately 55 kd which is approximately 80% of the 
total viral protein. A minor protein (L2) has a molecular size of approximately 
70 Kd. Both the proteins are virally encoded. Virus like particles can be 
produced from different PVs by expressing L1 alone or the combination of L1 
and L2 using mammalian or non mammalian expression systems.    
ELECTRON MICROGRAPH IMAGE OF HPV 
                                                     
III. REPLICATION 9,10  
 Papilloma virus is highly species specific and highly tropic for 
squamous epithelial cells of the skin and mucous membranes. The basal cell is 
the only cell in the squamous epithelium undergoing cell division. The virus 
must infect the basal cells to establish a persistent lesion. Viral nuclei acid can 
  
be found in basal stem cells but late gene expression (capsid proteins) is 
restricted to upper most layer of differentiated Keratinocytes. Stages in the viral 
replicative cycle are dependent on specific factors in sequential differentiated 
states of epithelial cells. There is a close link of the papilloma virus life cycle 
with the differentiation of the squamous epithelium. Late gene expression, 
synthesis of capsid proteins, vegetative viral DNA synthesis and assembly of 
virions occur only in terminally differentiating squamous epithelial cells.  
HPV Genome 11 
 The Genomic organization of all HPV types is similar. Three regions 
can be identified.  
1. A small non-coding region of 400 – 1000 base pairs that plays a 
regulatory role in DNA transcription and replication.  
2. An early region (ER) consisting of several genes (E1-E7) coding 
regulatory proteins in DNA transcription, replication and cell 
transformations.  
3. A Late Region (LR) that codes viral structural proteins L1 and L2.  
E1 is a helicase which binds and interacts with host DNA, E2 is 
involved in recruitment of E1 to the key target region & also has a role in 
repressing transcription.  
  
E1 –Activates telomerase – promotes continued cell proliferation and 
inhibits apoptosis. E7 – inactivates the tumour suppressor gene pR6 and allows 
the cells to enter the S phase.   
IV. GEOGRAPHIC DISTRIBUTION 12 
 Worldwide differences in the prevalence of genital HPV infection exist 
and are linked to regional variations in cervical cancer rates. HPV 16, the most 
common type detected in invasive cervical  cancer, has been classified into 5 
major lineages viz., Asian variants, American Asian variants, European 
variants, African  1 variants and African  2 variants. Studies also suggest that 
variants of HPV 16 and HPV18 to persist in a host where race indicates an 
ancestral geographic distribution that was once shared with that of the variant. 
Approximately 291 million women are HPV DNA carriers worldwide. 32% of 
the HPV infected women have high risk HPV types 16 & 18 from the general 
population. The median prevalence of high risk HPV by region was Africa 
(8%), America (11.1%), Eastern Mediterranean (13.7%), Europe (11.5%), 
South East Asia (13.9%), Western Pacific (6.9%). The prevalence of HPV type 
16 ranged from 1.1% to 38.9% across all regions2. The most common type 
reported among female sex workers included HPV 16 (38.9%) and HPV 18 
(23.1%)2.  
V. EPIDEMIOLOGY 
 The incidence and prevalence of clinical HPV genital infection is 
steadily increasing since the mid 1960’s. Current evidence suggests that over 
  
50% of sexually active adults (15- 25 years) have been infected with one or 
more HPV types. In the United States, the prevalence among men and women 
between 15 and 49 years of age with genital warts could be 1.4 million and 
with subclinical infection is 19 million. In Britain and Ireland every 80,000 
new cases of anogenital warts are reported every year. The prevalence of 
anogenital warts in India is reported to be 5.1% to 25.2% of STD patients. HIV 
infection may increase the incidence and prevalence of genital warts. The 
incidence of warts is reported between 5% and 27% in HIV Infected 
individuals. In a prospective study of 912 HIV-1 infected patients, 21% had 
common / plantars warts and 19% had condyloma acuminata.  
 Anogenital wart is the most common manifestation of sexually 
transmissible HPV infection, and prevalence peaks during the second and third 
decades of life. Prevalence rates of genital warts is between 0.6% and 13% 
depending on the population studied. Twenty year trends in the incidence and 
prevalence of diagnosed genital warts in Canada showed an incidence of 
149.9/10,000 in men and 170.8/100,000 in women in 1992 and appears to be 
increasing. Genital warts represent the tip of the iceberg of HPV infection. The 
spectrum of subclinical infection has several distinct entities namely aceto 
white epithelium, macroscopically normal epithelium but  cytological or 
histological evidence of HPV infection such as Koilocytosis and  macro and 
microscopically normal epithelium in which HPV has been detected by means 
like insitu hybridization or DNA amplification by PCR.  
  
The infectivity of patients with warts is well documented. Upto 65% of 
their sexual partners will develop warts in six months.  Genital HPV is less 
common in circumcised men and cervical cancer risk is less among female sex 
partners of circumcised men.  
 Around 70% of genital HPV infections clear within 1 year and 90% in 
two years. HPV 16 takes longer to be cleared by the immune system than other 
types having a medium duration of 8 months while it is 3 – 4 months for HPV 
6, 11 and 18.  
VI. TRANSMISSION OF HPV14 
 Genital HPV infections spread primarily through sexual contact. The 
infectivity of HPV among sexual partners is around 60%. During sexual 
intercourse, microabrasions occur in male and female genitalia and anus in 
Homosexuals. These microabrasions permit the transfer of HPV virions from 
the epithelial cells of the infected partner to the basal layer of recipient. It is 
still not proven if moisture and abrasions of the epithelial surface enhance HPV 
transmission. Transfer by fomites is not known to be responsible in acquiring 
genital HPV. Digital transmission is known and perinatal transmission has been 
observed in infants born to women having genital warts during pregnancy. 
These infants may develop laryngeal papillomas and congenital condylomas. 
This type of transmission is rare.  
VII. PATHOGENESIS 10 
  
 Spread of viral infections occur by close contact. Viral particles are 
released from the surface of papillomatous lesions and microlesions allow 
infection of proliferating basal layer cells at other sites or within different 
hosts. HPV types target epithelial cells. Their replication is dependent on the 
presence of differentiating squamous epithelium. Viral DNA alone can be 
detected in the lower layer of the epithelium while capsid (structural) proteins 
are found in superficial differentiated cell layers. The infectious virus from the 
epithelial cells enters through the microabrasions caused by trauma of the 
sexual act and reaches the basal layer of the recipient. In the absence of 
transformation, HPV follows the normal cycle of reproduction in the basal 
layer. Clinical and histopathological evidence of HPV infection develops 1-8 
months after initial exposure. These lesions regress spontaneously or persist as 
benign lesions.  
VIII. CLINICAL FEATURES13  
 Infection begins with viral entry and follows one of the three paths. 
Latent infection where the virus remains dormant without producing any or 
microscopic evidence of disease. Subclinical infection and clinical disease 
which is both asymptomatic and symptomatic. The lesions appear after an 
incubation period of 1-8 months with an average of 3 months.  
Infections of the genital tract – Genital warts.  
  
 In uncircumcised men the preputial cavity (frenulum, glans penis, 
 coronal sulcus, inner aspect of the foreskin) is  commonly affected. In 
circumcised men, the shaft of penis is often involved. Warts also occur on the 
scrotum, groin, perineum and anal area.  
 In females, the common sites are the posterior introitus, labia, perineum, 
and perianal area. Lesions also can be seen intravaginally or in the cervix but 
these areas are involved in subclinical infection. The urethral meatus is affected 
in 20-25% males and 4-8% of females. Anal warts are rarely found proximal to 
the dentate line. Intraanal warts are present when receptive anal intercourse is 
practiced. The colour of these warts can be pinkish raspberry to salmon red 
(non –keratinized warts), grayish white (heavily keratinised lesions) and ashen 
gray to brownish black (Pigmented lesions). Condylomata-tend to be 
nonpigmented and pigmented lesions are mostly seen on pigmented skin of 
labia majora, penile shaft, pubis, groin, perineum and anal areas.  
IX. CLINICAL TYPES OF GENITAL WARTS13  
1. Condyloma Acuminata :  
 The lesions are soft, pink, pedunculated,  papilliferous, cauliflower like 
masses with finger like peduncles and  irregular surface. They are mostly seen 
on moist  partially keratinized  epithelium such as the preputial  cavity, urinary 
meatus, labia minora, introitus, vagina, cervix, anus and anal canal. They may 
also affect intertriginous areas as well (groin, perineum and anal area).  
  
 Giant condyloma (Buschke – Lownenstein tumour) 
 This is a very rare variant of HPV 6 and 11 clinical manifestation 
characterized by aggressive downgrowth into the underlying dermal structures. 
The other types include  Papular warts, verruca vulgaris type or keratotic warts, 
sessile warts and flat warts.  
2. Intra epithelial neoplasia.  
 Bowenoid papulosis (BP) and Bowens disease (BD) are visible lesion 
associated with oncogenic HPV types commonly HPV 16, that exhibits full 
thickness intraepithelial neoplasia (IN–III).  BP appears at 25-35 years and BD 
at 40-50 years or older. BP presents as multiple, small, verrucous or velvetty 
often pigmented papules involving the anogenital region. 
X. SUB CLINICAL INFECTION  
 Subclinical HPV infections and latent infection are the most likely 
outcome after exposure to HPV. They are associated with symptoms such as 
itching, burning, fissuring and dyspareunia. Mucosal surface looks normal until 
acetic acid is applied, after which well demarcated, round white lesions may 
appear. In men, an entity called papilloma virus associated balanoposthitis is 
proposed. The clinical features include recurrent, painful fissuring of the 
frenulum, the coronal sulcus or the prepuce causing dyspareunia. In women, 
lesions are often found on the vulva, perineal and perianal area but seldom 
  
around the urethral  meatus. Treatment is offered to symptomatic patients. 
However,  subclinical infections are largely asymptomatic.  
Atypical lesions  
 They are brownish red or hyperkeratotic macules clinically identifiable 
by the naked eye without acetic acid application. Atypical lesions are found 
near clinically apparent lesions.  
Physical and psychosexual implications   
 Symptoms include inflammation, fissuring itching, bleeding or 
dyspareunia. Clinical lesions are disfiguring and can affect sexual life style. 
They cause feelings of guilt, anger, anxiety and loss of self esteem, and create 
concerns about future fertility and of cancer risk.  
Anogenital warts and pregnancy 
 Warts flourish in pregnancy and there is an increase in size and number 
of the lesions. This may be due to the increased  hormone levels, vascularity 
and immune deficiency which are seen in pregnancy. Large warts  may cause 
dystocia. Elective LSCS is preferred to prevent transmission of infection to the 
neonate. Even without treatment  warts may resolve  after delivery.  
Anogential warts in children  
  
 Genital warts in children may result from several modes of transmission 
such as acquisition at birth by HPV transmission from the maternal genital 
tract, autoinoculation from  finger warts, and non sexual transmission from 
family. Genital warts present at delivery are associated with a risk of 1 in 400 
of developing juvenile  laryngeal papillomatosis.  
Anogenital warts and  Immunosuppression  
Immunosuppression as a consequence of HIV infection and 
iatrogenically  as a result of transplant grafting is linked to a significant 
increase in multicentric and refractory condylomata and in intraepithelial 
neoplasia. Hence annual cytological screening of HIV positive and allografted 
women is advised.  
Genital HPV infection and cancer  
 Cervical cancer is the second most common cause of death from cancer, 
after breast cancer among women worldwide. The association between HPV 
infection and cervical cancer was first suggested in the 1970’s. Several 
epidemiological and molecular studies provided extremely strong evidence for 
the role of HPV as an etiological agent in cervical cancer and other anal and 
genital tract malignancies.  
 Over 99% of cervical cancer and over 80% of anal cancer cases are 
linked to genital infections with HPV. Anal cancer is associated with high risk 
  
HPV infection. Immunocompromised patients, Men who have sex with men, 
and HIV infected men are especially at risk. 
Anal HPV infection is sexually transmitted in most instances and a 
history of receptive anal intercourse in women and of homosexual activity in 
men is associated with an increased risk of this cancer. The risk of anal cancer 
is much lower in the general population. Most anal cancers arise in the 
transition zone between columnar & squamous epithelium.  
Head and neck cancers  
 HPV associated cancers are located in the oropharynx including tonsils, 
tonsillar fossae, base of the tongue and soft palate. HPV positive tumours  have 
a characteristic basaloid morphology and genital-oral sex may be a risk factor 
for these tumors.  
Penile Intraepithelial neoplasia, Vulval intraepithelial neoplasia and Anal intra 
epithelial neoplasia (AIN).15 
 These squamous intraepithelial lesions (SIL) are divided into three basic 
types. 
(1) Subclinical, appearing only  following the application of acetic acid 
(2) Resembling flat warts  
(3) Thirdly and most distinctive  red velvetty resions which have an eroded 
appearance because there is no normal epithelium.  
  
SIL are classed as low grade or grades (1) and high or grade (2) or (3).  
Majority of low grade lesions being associated with non oncogenic HPV type 6 
and 11 and majority of grade 3 lesions being caused by oncogenic HPV types, 
predominantly 16 and 18. Low grade lesions rarely show malignant  potential 
whereas high grade lesions  undergo malignant change.  
Recurrent largyngeal papillomatosis 9 
 Laryngeal papillomatosis is  rare. The papillomas may severely 
compromise, the airway particularly in young children. The vocal cords of the 
larynx is the most common site affected but papillomas can arise at other sites 
like trachea, lungs, nose and oral  cavity.  Most lesions are caused by genital 
HPV types causing external genital warts especially types 6 and 11. RRP( 
Recurrent Respiratory Papillomatosis) occur both in children and adults. Most 
cases of RRP that arise in early childhood are attributable to intrapartum 
transmission of HPV.  A history of oro genital sex is a risk factor in adult RRP. 
RRP is associated with a low risk of spread to the bronchi, and lungs, 
progression to severe dysplasia and even to cancer.  
Oncogenic types 13 
 HPV associated with anogenital infections are classified based on their 
oncogenic risk into the following:  
Low or no oncogenic risk – HPV types 6, 11, 42, 43 and 44. 
  
Intermediate risk- HPV types 31, 33, 35, 51, and 52 and 
High risk- HPV types 16, 18, 45, 46.  
More than 20 types of HPV are associated with cervical cancer. HPV 16 
is most commonly linked with cancer since it is present in 50% of cervical 
carcinomas. HPV type 18 is a very high risk type and its association with 
cervical lesions has a poor prognosis. Apart from cervical carcinoma, 
oncogenic HPV have been detected in other anogenital cancers. Bowenoid 
papulosis (HPV types 16, 34, 37, 42) penile carcimoma (HPV types 16 and 18) 
and anal carcinoma (HPV 16, 18 and 33).  
MECHANISM OF ONCOGENESIS13 
 Infection with HPV is one step in the multifactorial causation of 
malignancy. DNA from HPV types that are commonly found in anogenital 
cancer alters the growth of cells they infect, in a way that converts them to 
immortalized cell lines capable of continued replication. In benign HPV 
associated lesions, the viral genome exists separate from the host cell DNA 
replicating as an extrachromosomal plasmid. In malignant lesions associated 
with HPV16 and 18, the viral DNA is integrated into the host genome. 
Integration in to host DNA involves breakup of the viral genome. This results 
in the loss of function of the early E1/E2 regulatory genes associated with 
replication and transcription of the virus and a deregulation of the E6/E7 genes 
associated with cellular transformation. E6/E7 genes of the virus possibly cause 
  
transformation of HPV infected cells by interfering with the function of the P53 
protein (E6) and the Rb retinoblastoma gene product (E7).  Both these proteins 
are termed as `anti-oncogenes’ as they play a role in preventing cellular 
 transformation by suppressing cellular division and proliferation.  
Genital and related lesion associated with HPV15 
Lesions - Predominant HPV types 
Condyloma acuminata  - 6, 11 
Buschke – Lowenstein 
tumour 
- 6, 11 
Recurrent respiratory 
 papillamatosis 
- 6, 11 
Carcinoma of head, neck 
and lung 
- 16, 18, 30 
Oral papilloma - 6, 7, 11, 16, 13 (72, 73 also in HIV  patients) 
Cacinoma of cervix - 16 (55%) 18 (16%) global averages (WHO 
Data) 
Predominant minor  types : 31, 33, 35, 39, 45, 
51, 52, 56, 58, 59, 66 
CIN 1 - Compared with cervical  cancer prevalence of 
16/18 is halved and prevalence of minor types 
is higher (WHO data) 
  
CIN 2/3 - 16 (42%) 18(7%) 31 (7%) 58 (8%) WHO data  
Carcinoma of penis  - 16 (59%) Predominant minor  types 18, 35, 45 
Carcinoma of anus - 16 (87%), 18 (7%), 33 (6%), 31(1%) 
Other types occasionally 
associated  with 
malignancy 
- 40, 42-44, 53, 54, 59, 61, 68, 70, 72, 73, 81, 82 
 
IMMUNOLOGY OF WARTS 
 Inability to propagate HPV in the laboratory is a roadblock on the 
investigation on the immunology of warts. Both cell mediated and humoral 
immunity have been documented in patient with genital warts but CMI appears 
to be important. Increase in the CMI has been shown to be effective in 
regression, controlling reactivation, prevention of recurrence and elimination of 
warts. Patients with deficient CMI (HPV patients, renal transplant patients 
receiving immunosuppressive drugs) have increased incidence of warts.  
 Various studies show that human sera have antibodies that reacts to 
HPV protein in patients with regressinig warts. IgM (100%) IgG (97%) and 
IgA (80%) classes of antibodies to HPV antigens have been detected. In 83% 
of these patients IgM  class of antibodies to virus infected cells are also found. 
Patients with complement fixing IgG antibodies had a higher cure rate and a 
shorter duration of warts (less than a year). Though circulating antibodies are 
  
detected in patients with warts, they do not help in clearance of the lesion or in 
the prevention of recurrences.  
CLINICAL DIAGNOSIS / INVESTIGATIONS 13 
 The diagnosis of anogenital warts is based on the history of exposure, 
clinical appearance and epidemiological proof of the warts in the sexual 
contact. In both sexes careful examination of the external genitalia is performed 
with a clear and powerful light.  All women with anogenital warts should have 
a speculum examination. It is essential to look for concurrent STDs and tests 
for them should be offered.  
THE ACETIC ACID TEST  
 Following the application of 3%-5% acetic acid, the HPV lesions turn 
grayish white. The whitish appearance is attributed to an over expression of 
cytokeratin 10 in the HPV infected suprabasal cells. The test has low 
specificity and sensitivity and not recommended for screening purposes. It can 
be used for visualizing subclinical genital HPV associated lesions.  
COLPOSCOPY 
 Higher sensitivity for low grade CIN 
MEATOSCOPY 
 Inspection of fossa navicularis in men is done by using a small 
speculum.  
  
 
PROCTOSCOPY  
 Concurrent perineal and perianal warts exist in 1/3rd of patients.  Hence 
proctoscopy is indicated.  
SOUTHERN BLOT HYBRIDIZATION 
 This technique is the Gold Standard among HPV DNA 
detection methods with a sensitivity range between 0.1 and 0.01 viral copies 
per cell but it is too time consuming and labour intensive for routine diagnosis.  
IN SITU HYBRIDIZATION  
 It helps in determining the localization of HPV DNA, within the 
specimen. Biotinylated probes are more stable and do not expose the staff to 
radioactivity.  
POLYMERASE CHAIN REACTION  
 This is the most sensitive method for detection of HPV DNA, being able 
to detect one viral genome in 1,00,000 cells.  It is able to detect latent infection 
but has little benefit in routine diagnosis and management and is primarily a 
research tool. 
HISTOPATHOLOGICAL EXAMINATION  
  
 Parakeratotichyperkeratosis, moderate granulomatosis, pronounced 
acanthosis, papillomatosis & presence of mitotic figures. The characteristic 
features important for diagnosis are the presence of koilocytes which are 
mature squamous cells with a large, clear perinuclear zone and smudgy nuclei 
scattered throughout the outer cell layers.  
TREATMENT 
 The three main therapeutic goals are  
1. Induction of wart free periods to allieviate anxiety and to reduce the risk 
of transmission of HPV.  
2. Therapy that is no worse than the disease.  
3. Reduce morbidity and  mortality for  cervical cancer.  
Treatment options may be categorized as  
Cyto destructive methods  
Surgical excision   
Cryotherapy  
Laser therapy 
Bichloracetic or trichloracetic acid 
Podophyllin 
Podophyllotoxin 
  
Anti metabolite therapy (5- FU) 
Antiviral  therapy (Cidofivir and interferons) (IFN’s) 
Immunomodulation (imiquimod) 
They have also been classified as  
Home therapy: podophyllotoxin (0.5 solution or 0.15% cream) and 
imiquimod  
Hospital therapy: Electrosurgery, laser ablation curettage or scissors 
excision, cryotherapy, TCA or carbolic acid and Podophyllin.  
Therapies generally not recommended IFNs and 5-FU.  
PODOPHYLLIN 
It is used as 10% to 25% solution dissolved in tincture of benzoin. It is a 
first line therapy and cheap with common clinical use due to spectacular 
initial effects. Ethanol extract is prepared from the dried rhizome and 
roots of an American plant podophyllum peltatum and P.emodi, an 
Indian Plant which is a complex resinous material containing 
podophyllotoxin,  alpha peltatum and betapeltatum. 
Podophyllin inhibits mitosis at metaphase and causes swelling & 
necrosis of cells..  
  
Applied to the warts by a physician using a cotton tipped swab once or 
twice a week for up to six weeks. The surrounding skin is protected with 
Vaseline, zinc cream or both. 4 hrs after application  it is completely 
washed off. After six sittings, if the warts persist other treatment 
 modalities need to be considered. 
The wart clearance rate at the end of treatment is 32%-79%.Podophyllin 
is contraindicated in pregnancy as it can lead to fetal death and 
abortions. Podophyllin – prolonged use is not advocated for the fear of 
its oncogenic potential due to its two chemical mutagens (quercetin  and 
kaempherol).  
COURSE AND PROGNOSIS  
 The natural course of genital warts spans from limited easily treatable 
disease to extensive progressive disease resulting in intraepithelial neoplasia or 
invasive squamous cell carcinoma.  
PREVENTION AND CONTROL10,14,15 
 Vaccines against HPV are expected to be a cost effective way to reduce 
 anogenital HPV infections, the incidence of cervical cancer and the HPV 
associated health care burden. A quadrivalent HPV vaccine was approved in 
the United States in 2006 and a bivalent vaccine in 2007. Both are 
noninfectious recombinant vaccines containing virus like particles composed of 
HPVL1 proteins. The Quadrivalent vaccine contains particles derived from 
  
HPV types 6, 11, 16, 18 (Gardasil) and bivalent vaccine contains VLP’s 
derived from HPV types 16 and 18 (cervarix - GSK).  
 The mode of action of these vaccines is thought to be the induction and 
production of anti-L1 antibodies. The VLP’s are potent immunogens and given 
intramuscularly which ensures rapid dissemination of the antigens to the lymph 
nodes. This results in high levels of neutralizing antibodies, which are able to 
bind to virus and prevent entry and infection of cells. Both vaccines are 
effective at preventing persistent infections by the targeted HPV types and the 
development of HPV related genital precancerous lesions. The striking features 
of these 2 vacccines has been the near 100% protection from clinical diseases 
such as high grade CIN2/3 which are accepted as the precursor lesions of 
 malignant transformation. Both vaccines will protect against approximately 
70% of cervical cancer cases. The vaccines have provided a degree of cross 
protection against subtypes not included in the vaccine such as type 45 and 31. 
The current vaccines are expected to offer a degree of protection against all 
HPV related cancers such as other anogenital cancers (ie anal, vulval, vaginal, 
penile etc.) and subsets of head and neck cancers in which the dominant sub 
types are HPV 16 and 18. The quadrivalent vaccine will additionally protect 
against the development of genital warts and recurrent respiratory 
papillomatosis.  
 The HPV vaccine is recommended for 11–12 year old girls (range 9–26 
years). Ideally the vaccine is administered before the onset of sexual 
  
activity.Young men, especially men who have sex with men (MSM) who carry 
a significant risk of infection should also be vaccinated. Men could be 
protected against both warts and HPV related cancers and their vaccination 
would also benefit herd immunity.  
 The HPV vaccine has been tested in over 11,000 females  
(9-26 years of age) in many countries around  the world. These studies found 
that HPV vaccines were safe and caused no serious side effects.  
 The vaccine is not effective against established disease and are not 
recommended for pregnant females. The vaccine induced immunity lasts for 5 
years.  
 The vaccine should be delivered through a series of three intramuscular 
injections over a six month period. The second and third doses should be given 
2 and 6 months after the first dose.  
HPV VACCINE EFFICACY 
 The clinical trials have demonstrated 100% efficacy in preventing 
cervical precancers caused by the targeted HPV types and nearly 100% 
efficacy in preventing Vulvar and vaginal precancers and genital warts caused 
by the targeted HPV  types.  
HPV AND HIV INTERACTION 9 
  
 The risk of genital HPV infection may be high for HIV infected 
individuals because infection by both viruses is often through sexual 
transmission and it is well known that exposure to one sexually transmitted 
agent puts an individual at higher risk for exposure to other 
sexually transmitted agents. Cervical HPV infection is detected more 
frequently in HIV positive women  than in those who are HIV negative. The 
infection is likely to persist, result in cytologic abnormalities and a much 
greater risk is seen for high grade dysplasia. In a prospective study of women at 
high risk for HPV  infection in New York, cervical swabs taken at the initial 
examination detected HPV DNA approximately twice as frequently in HIV 
positive women compared with HIV negative women (56% versus 31%) 
persistent infection was  6 times as frequent in the HIV positive women (24% 
versus 4%), Low grade dysplasia (C1N1) was about three times as frequent in 
HIV positive women (13% versus 4%) whereas high grade dysplasia was seven 
times  more frequent (7% vs 1%). Low CD4 counts in HIV positive women 
represent  an independent risk factor.  
 HIV infection represents a risk factor for other malignancies  associated 
with HPV infection including cancers of the vulva, penis and anus. The relative 
risk for anal cancer is especially high for HIV infected male  homosexuals.  
 Studies have reported that 26% to 60% of HIV seropositive men and 
15% to 29% of seronegative men have anal  HPV DNA.  
MECHANISMS OF INTERACTIONS BETWEEN HIV AND HPV14  
  
 Alterations in the natural history of HPV infection and of HPV related 
neoplasia among HIV seropositive individuals are the result of general or local 
HIV induced immunesystem dysfunction. Control of HPV is improved when 
large number of lymphocytes  or Langerhans cells in the area are infected with 
HIV. It is also possible that HIV act directly on HPV. In vitro studies have 
shown that intracellular HIV 1 tat m RNA can transactivate HPV type 16 E6 & 
E7 a step that is important in development of squamous cell neoplasia. In vitro 
studies have also shown that extracellular HIV-1 tat protein can enter HPV 
infected cells and upregulate HPV type 16 E6 and E7. The HIV-1 tat protein 
enhances E2 dependent HPV type 16 transcription. Extracellular tat migrates 
from Langerhans cells or other HIV infected mononuclear cells that abut HPV 
infected epithelial cells and upregulate  HPV.  
TYPES OF COMMON SEXUALLY TRANSMITTED INFECTIONS16,17 
BACTERIAL                                                                        PARASITIC 
Gonorrhoea                                                                             Trichomoniasis 
Bacterial vaginosis 
Syphilis 
  
VIRAL                                                                                    FUNGAL 
Human Papilloma Virus                                                           Candidiasis 
Human Immuno deficiency virus 
  
Herpes Genitalis 
Hepatitis B and C virus 
GONORRHOEA 
Niesseria Gonorrhoeae is a gram negative intracellular diplococci which 
affects the mucous membrane of the genito urinary tract, eye, rectum and throat 
causing acute suppuration, tissue invasion followed by chronic inflammation 
and fibrosis. In males it causes urethritis and in females it affects the 
endocervix producing mucopurulent discharge. Gram stained smears of the 
endocervix or the urethral exudates shows many intracellular gram negative 
diplococci within pus cells. Stained smears from urethral exudates in men have 
a sensitivity of about 90% and a specificity of about 99%. In women, stained 
smears from endocervical exudates have a sensitivity of about 50 % and a 
specificity of about 95%. Cultures of urethral exudates from men are not 
necessary when the gram stain is positive but cultures are done for women. 
BACTERIAL VAGINOSIS 
It is a clinical syndrome with the symptoms of increased vaginal 
discharge with foul smelling fishy odour which is more offensive after sexual 
intercourse. Gardnerella Vaginalis, Prevotella spp, Peptostreptococci, 
Mobiluncus spp, Mycoplasma hominis are closely associated wth bacterial 
vaginosis. The accepted standard for the diagnosis of bacterial vaginosis has 
been the Amsel’s criteria(thin homogenous vaginal discharge, increased 
vaginal pH, presence of amines detected by fishy odour after addition of KOH 
  
to the discharge and the presence of clue cells). Alternative to this method is 
the Nugent’s scoring in which the grading or scoring of the gram stained 
vaginal smear to detect the changes in vaginal ecology. 
SYPHILIS 
Treponema Pallidum, the causative agent of syphilis is actively motile 
slender spirochaete which can be seen only under dark ground illumination. 
Natural infection with T.Pallidum is restricted to human host and transmitted 
by sexual contact. Both the primary lesion( hard chancre) and the secondary 
lesion(rash and condyloma) are highly infectious and rich in spirochaetes. 
Laboratory diagnosis is by examination of tissue fluid for motile spirochaetes 
by dark field microscope and serological tests which are non specific (RPR) 
and specific (TPHA, FTABS, TPI tests).  
TRICHOMONIASIS 
Trichomonas Vaginalis is a pear shaped parasite affecting both man and 
women, transmitted commonly by sexual intercourse. In females the infection 
is limited to vulva, vagina or cervix. In males urethra, prostrate and seminal 
vesicles may be infected. Females tend to have a profuse frothy yellow 
discharge while males have a thin urethral discharge which shows 
characteristic motile trichomanads in wobbling or rotating motion. 
 
 
  
CANDIDIASIS 
Candidial vulvovaginitis is the second most frequent cause of vaginal 
infection more common in immunocompromised and diabetic patients. Patient 
presents with thick white vaginal discharge. Microscopic examination of KOH 
mount and Gram stain from the discharge shows budding  yeast cells and 
pseudohyphae . 
HIV  
 
Human immunodeficiency virus is an enveloped RNA virus belonging 
to the lentivirus subgroup of retroviruses. HIV is present in semen, vaginal and 
cervical secretions and blood, the main vehicle by which the virus is 
transmitted. HIV is mainly transmitted by heterosexual intercourse(85 to 95%) 
transmission, anal intercourse, vertical transmission, transfusion of unscreened 
blood, use of contaminated syringes and needles and by intravenous drug users. 
HIV screening is done by rapid HIV antibody tests which are highly sensitive   
and specific. ELISA (Enzyme Linked ImmunoSorbent Assay) for HIV 
antibody screening is done in blood transfusion centres and for surveillance 
testing. 
HERPES GENITALIS 
 
Herpes simplex virus is an alpha herpes virus among the herpes virus 
family. It is fast growing, cytolytic and have latent infection in neurons of the 
host. Genital herpes is predominantly caused by human herpes virus 2 and also 
  
by human herpes virus1. It affects the mucosal surfaces and damaged 
cutaneous sites. The lesions are Vesiculo ulcerative in the penis and vesiculo 
ulcerative lesions of the cervix, vagina, vulva and perineum in females and are 
painful associated with fever, malaise, dysuria and inguinal lymphadenopathy. 
Laboratory diagnosis include skin scrapings obtained from the base of the 
vesicle stained with Giemsa stain will show the multinucleate giant cells                     
( TZANCK SMEAR)  which is indicative of herpes virus. The virus can be 
isolated from CSF, throat, urine, stool, nasopharynx and conjunctiva by PCR 
and serological assay can be done to detect antibodies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
MATERIALS AND METHODS 
PLACE OF STUDY 
(1) Department of Microbiology, Stanley medical college, Chennai 
(2) Department of Sexually Transmitted Diseases’ Stanley medical college and 
Hospital, Chennai. 
STUDY DESIGN 
Prospective study 
SAMPLE SIZE 
200 
STUDY PERIOD 
September 2014 to September 2015 
ETHICAL CONSIDERATION 
Ethical and research clearance was obtained from the Ethical committee, 
Stanley medical college. Permission to conduct the study was sought from the 
respective hospital department authorities. Personal interview was conducted 
by the author with every patient. A standard proforma was filled up at the time 
of interview and Informed consent was obtained from the patients before 
enrollment into the study. 
 
  
STATISTICAL ANALYSIS 
The collected data was analysed with SPSS 16.0 version. To describe 
about the data descriptive statistics frequency analysis, percentage analysis 
were used for categorical variables and the mean & S.D were used for 
continuous variables. To find the significance in categorical data Chi-Square 
test was used. In the above statistical tool the probability value .05 is 
considered as significant level.  
INCLUSION CRITERIA 
1. Female sex workers [FSW] 
2. Male having sex with male [MSM] practicing commercial sex 
3. Transgenders [TG] practicing commercial sex 
4. Men above 18 years attending STD clinic with history of 
PROMISCUOUS sexual activity- Having multiple sex partners in one 
year duration. 
5. Women above 18 years attending STD clinic with history of 
PROMISCUOUS sexual activity- Having multiple sex partners in one 
year duration. 
6. FSW, MSM, TGs, Promiscuous men and women with other symptoms 
of sexually transmitted diseases. 
 
 
  
EXCLUSION CRITERIA 
1. Men above 18 years attending STD clinic without history of 
promiscuous sexual activity. 
2. Women above 18 years attending STD clinic without history of 
promiscuous sexual activity. 
3. Pregnant women. 
SPECIMEN COLLECTION AND LABORATORY TESTING 
SPECIMEN COLLECTION 
URETHRAL SWAB15 
The specimen was collected after wearing sterile gloves one hour after 
patient has urinated. After retracting the prepuce, the tip of the meatus was 
cleaned with normal saline and if purulent discharge was seen it was collected 
using a sterile swab. If no discharge was seen, milking of the urethra was done 
towards the orifice to obtain the discharge. Three swabs were taken one for 
gram’s stain one for wet mount and another was placed in 70% ethanol in a test 
tube for viral isolation. 
THROAT SWAB18 
It was made sure that the patient was not treated with antibiotics or 
antiseptic mouth washes 8 hours before swabbing. 
In a good light and using the handle of a tongue depressor the tongue 
was depressed and inside of the mouth was examined. Swabbing was done in 
  
the posterior pharyngeal wall and peritonsillar area using a sterile cotton wool 
swab. Two swabs were taken one for gram’s stain and another placed in 70% 
ethanol for viral isolation. 
CERVICAL SWAB/HIGH VAGINAL SWAB 
Sterile vaginal speculum was used to examine the cervix and the 
specimen was collected. Speculum was moistened with sterile warm water and 
inserted in to the vagina. Cervix was cleaned using a swab moistened with 
sterile physiological saline. A sterile Dacron swab is passed 20mm-30mm in to 
the endocervical canal and gently rotated against the endocervical wall to 
obtain a specimen. Three swabs were taken one for gram’s stain one for wet 
mount and one was placed in 70% ethanol in a test tube for viral isolation 
COLLECTION OF VAGINAL DISCHARGE17 
Wet mount to detect motile T. Vaginalis- Using a sterile Dacron swab 
specimen is collected from the vagina and the exudate is transferred to a 
microscope slide to which a drop of normal saline is added and mixed and then 
covered with a cover glass. 
Direct smear for Gram staining to detect Candida and examine for clue 
Cells-  
Using a sterile Dacron swab specimen was collected from the vagina. 
Sample of the exudate is transferred to a microscope slide and then spread to 
make a thin smear. Smear was air dried and heat fixed for gram staining. 
  
 
KOH mount to detect candida  
Using a sterile Dacron swab specimen was collected from vagina. A 
drop of 10% KOH is placed over the microscope slide. The sample is 
transferred to the slide and a cover glass is applied over it. 
RECTAL SWABS 
Specimen was collected using a sterile cotton wool swab. After the 
insertion of proctoscope,  moist swab was introduced in to the rectum for about 
2 to 4cm. Swabs were taken avoiding unnecessary contamination of the 
specimen with bacteria from the anal skin. Swabs with heavy feacal 
contamination are discarded. Two rectal swabs were taken one for gram’s stain 
and another placed in 70% ethanol for viral isolation. 
 
BLOOD 
5ml of venous blood collected from each patient with strict aseptic 
precautions  and serum was separated by keeping the test tube in a 45* slanting  
position  at 4 to 8*c for 4 to 6hours or by centrifuging at 1500 rpm for 5-10 
minutes. Then the serum was tested for HIV as per NACO guidelines19 and 
RPR for Syphilis was done. The samples that were found to be reactive with 
RPR are confirmed by performing TPHA test. 
 
 
  
PROCESSING OF THE COLLECTED SPECIMEN  
 
Neisseria gonorrhoea 
Microscopy 
With one swab, on a clean grease free slide, smear was prepared by 
rolling the swab. One directional smearing technique minimizes distortion and 
breakage of Polymorphonuclear leukocytes (PMNL) and thereby preserves the 
characteristic intracellular appearance of this microorganism. The smear was 
air dried and methanol fixed. Gram stain was done using saffranin as 
counterstain and examined with light microscope under oil immersion 
objective.  
 
Interpretation 
The smear was examined for epithelial cells, Polymorphonuclear 
leucocytes (pus cells), organisms and their location whether extracellular or 
intracellular. The gonococci are intracellular; bean shaped and are usually 
arranged in pairs, 0.8µm x 0.6µm in size. They are Gram negative in reaction 
and are stained pink along with the nuclei and protoplasm of pus cells. The 
slide was examined for at least 2 minutes before declaring as negative for 
gonococci. 
Trichomonas vaginalis 
Microscopy 
A drop of discharge or urine sediment was put on a clean grease free 
microscope slide. One drop of normal saline was mixed with sediment and a 
  
cover slip was placed over it. The slide was observed first under 10 x 
magnification. Any field which shows the suspected organism is then seen 
under 40 x magnification of light microscope. 
Interpretation 
Trichomonads are 15 µm in size, they have a pyriform shape with an 
anterior tuft of flagella and a lateral undulating membrane, the parasite moves 
actively, showing jerky motility, Centrifuged samples do not show motility 
because the flagella are detached during centrifugation. 
Stainings 
On a clean grease free microscope slide smear was prepared from 
sediment. Then the smear was allowed to dry in air, fixed with methanol and 
stained with Giemsa stain. Stained smear was observed under oil immersion. 
 Candida species 
 KOH MOUNT (10%) FOR CANDIDA 
 Place a drop of 10% KOH (Potassium hydroxide) on a microscope 
slide. Transfer the specimen to the slide and apply a cover glass over it.KOH is 
a strong alkali and hence it clears the epithelial cells ,and digests the keratin 
around the fungi so that the fungal elements can be seen clearly.Clearing can be 
hastened by gently heating the preparation over the flame of a Bunsen burner 
taking care not to prevent drying or splatter of corrosive KOH solution. 
Examine the slide under 10x and 40x of the light microscope. 
Budding yeast cells and pseudohyphae can be seen. 
  
Gram Staining 
A smear was prepared on a clean microscope slide, air dried and heat 
fixed and stained by Gram’s Method and observed under oil immersion. 
Interpretation 
Gram positive budding yeast cells and pseudohyphae. 
BACTERIAL VAGINOSIS16,20 
The collection of material is done using a speculum. Speculum 
examination is made and   the nature of the discharge is evaluated. Specimen 
from the lateral vaginal wall and posterior fornix is taken with a sterile swab. 
The classical BV discharge is thin, homogeneous and grey/yellow in color 
while the absence of the classic discharge does not rule out disturbed vaginal 
flora. 
 The diagnostic methods used are either laboratory based or clinical 
'bedside' testing. For the purposes of laboratory based testing the swab was 
rolled across a slide and the material allowed to air dry. In the laboratory, the 
smear should be heat-fixed and Gram-stained.  
In the methodology by Nugent et al, the swab was obtained from the 
lateral vaginal wall and rolled on a glass slide. The smears were then heat fixed 
and Gram stained using safranin as the counterstain. The smear was then 
evaluated for the following morphotypes under oil immersion 
  
(1000xmagnification): large Gram-positive rods (lactobacillus morphotypes), 
small Gram-variable rods (G vaginalismorphotypes), small Gram-negative rods 
(Bacteroides species morphotypes), curved Gram-variable rods 
(Mobiluncus species morphotypes) and Gram-positive cocci. Although Gram-
positive cocci are not part of the scoring system, some laboratories will report 
them if they are present in significant numbers. Increased numbers of Gram-
positive cocci are not part of the pattern of the normal vaginal flora. A score of 
zero to three is considered to be normal, four to six is considered intermediate 
and seven to ten is defined as Bacterial Vaginosis. Intermediate vaginal flora is 
reported to the clinician for management based on the clinical context. Thirty 
two per cent of patients with an intermediate score will proceed to BV and 30% 
to normal flora. Even though clinical methodology is useful because it allows 
for an immediate answer in certain urgent clinical situations, but the Gram stain 
method appears to be more accurate. 
 
SL 
No 
Organism Morphotypes Number/ oil 
immersion field 
Score 
1 Lactobacillis-like (parallel-sided, 
gram positive rods) 
 
 
>30 
5-30 
1-4 
<1 
0 
0 
1 
2 
3 
4 
2 Mobiluncus–like (curved, gram 
negative rods) 
>5 
1-4 
0 
 
2 
1 
0 
3 Gardernerella/bacteriods like(tiny, gram 
variable coccobacilli and rounded, 
pleomorphic, gram negative rods with 
vacuole) 
 
>30 
5-30 
1-4 
<1 
0 
4 
3 
2 
1 
0 
  
0-3 normal 
4-6 intermediate, test to be repeated later 
7-10 bacterial vaginosis 
GENITAL ULCER SYNDROME 
The exudates from the base of the ulcer is examined by making a wet 
mount to detect spirochaetes under dark ground illumination, Tzanck smear 
(1% aqueous toluidine blue) to look for multinucleated giant cells and gram 
stain done to detect other organisms.  
ISOLATION OF CELLS FROM THE SWAB 
The swab placed in 70% ethanol in a test tube is vortex mixed to loosen 
the cells in the swab and then the swab was discarded. The test tube containing 
70% ethanol and the collected cells is centrifuged at 8000rpm for 1minute so 
that the cells get deposited at the bottom of the tube.The 70% ethanol is 
discarded leaving the celldeposits in the tube to which 0.5ml of PBS buffer is 
added. The cell deposit is transferred to a 1.5ml microcentrifuge tube for DNA 
isolation. 
POLYMERASE CHAIN REACTION- ISOLATION OF VIRAL NUCLEIC 
ACID 21 
PRINCIPLE 
Cells are lysed during a short incubation with choatrophic salt,which 
immediately inactivates allnucleases. Cellular nucleic acids bind selectively to 
special glass filters prepacked in the purification filter tubes. Bound nucleic 
  
acids are purified in a series of rapid wash and spin steps to remove the 
contaminating cellular components.A special inhibitor removal buffer has been 
included which removes inhibitors from the preparation. Finally elution buffer 
releases nucleic acids from the glass fiber. This simple method eliminates the 
need for the organic solvent extractions and nucleic acid precipitation allowing 
for purification of many samples simultaneously. 
MATERIALS REQUIRED 
1. Micropipettes of variable volume 0.5-10, 10-100,and 100-1000. 
2. Sterile pipette tips with aerosol barrier 2-20,10-100 and 100-1000. 
3. Disposable powder free gloves. 
4. Vortex mixer/ water bath 
5. Centrifuge with rotor for 1.5ml reaction tubes. 
6. 1.5ml/2ml centrifuge tubes. 
PROCEDURE 
Before use all the reagents were thawed completely mixed and centrifuged 
briefly. 
1. The following reagents areadded to  a nuclease free 1.5 ml centrifuge 
tube. 
a. 200microlitreof lysis buffer 
b. 5microlitre of carrier RNA 
c. 200microlitre of cell deposit 
d. 20 microlitre of Proteinase  K 
e. 5 microlitre of internal template control. 
  
2.  Centrifuge tube was mixed immediately by inverting it. 
3.  The tube is incubated for 15 minutes @56*in a water bath. 
4.  After taking the tube from the incubator 300µlitres of 100% ethanol was 
added and mixed by a vortex mixer for 30 seconds. 
5.  Then the tube was centrifuged for few seconds  to bring down the drops 
to the bottom of the tube. 
6.  Entire sample was then transferred to a pure fast spin column. 
7.  The pure fast spin column was centrifuged at 12000rpm for one minute. 
8.  The flow through was discarded and column was placed back into the 
same collection tube. 
9.  To this 500microlitre of 70% ethanol was added to the pure fast spin 
column. 
10.  The pure fast spin column was centrifuged at 12000 rpm for 1 minute 
and the flow through was discarded and column was placed back in to 
the same collection tube. 
11. The empty spin column was attached with the collection tube and 
centrifuged at 12000 rpm for an additional 2 minutes to avoid residual 
ethanol and the collection tube was discarded. 
12. The pure fast spin column was then transferred to  a fresh 1.5ml micro 
centrifuge tube. To this 50 microlitre of elution buffer was added to the 
  
centre of the pure fast spin column membrane and incubated for 
2minutes at room temperature. 
13. The pure fast spin column and the centrifuge tube was centrifuged at 
12000 rpm for 1minute and the pure fast spin column was then 
discarded. 
14. Now the centrifuge tube containing the eluted nucleic acid was stored at 
-80*c for later analysis. 
PREPARATION OF AGAROSE GEL 
2% Agarose gel was prepared by adding two grams of agarose powder 
to 100ml of electrophoresis buffer, then heated in a microwave oven for 3 
minutes and mixed until the agarose was evenly dissolved. After cooling to 
about 60*c ,5microlitre of ethidium bromide was added to 100ml of the gel to 
enable  visualization of DNA after electrophoresis. Ethidium bromide being 
carcinogen should be handled with precaution. 
A well formed COMB plate was placed across the end of the casting 
tray which is covered with a cellophane tape in its both ends and the freshly 
prepared gel was poured into the casting tray which acts as a mold. This was let 
to solidify at room temperature. 
PREPARATION OF ELECTROPHORETIC BUFFER 
Electrophoresis [TAE- Tris Acetic Acid-EDTA] buffer was prepared in 
a 50 X dilution. To prepare a 1000ml of buffer , 980ml of distilled water and 20 
  
ml of buffer is added and poured in to a electrophoretic tank. After the gel has 
hardened enough, the gel was gently placed  on the electrophoresis tank with 
buffer and  was made sure that the gel was completely immersed in the buffer.  
MULTIPLEX POLYMERASE CHAIN REACTION FOR HUMAN 
PAPILLOMA VIRUS 16 AND 18 
The kit components include PCR master mix, HPV 16 & 18 primer mix, 
endogenous primer mix, HPV 16 & 18 positive template and nuclease free 
water. The kit contains all reagents and enzymes for the specific amplification 
of E6/ E7 region of the HPV genome. In addition it contains an endogenous 
control system to identify possible PCR inhibition and to validate DNA 
purification.   
MASTER MIX 
Master mix is prepared taking 10µl of master mix and 10µl of HPV 16 
and 18 PRIMER MIX for one sample and mixed together. 20µl of this mixture 
is added to a 0.2 ml PCR tube to which 5µl of sample is added. Endogenous 
control, positive and negative controls are also added in the similar method. 
The primer sequence of HPV 16 and HPV 18 used in this procedure are: 
HPV 16 
5’-GCAACAGTTA CTGCGACGTGAGGT-3’ 
5’-CACACAA CGGTTTGTTGTATTGCTGT-3’ 
  
HPV 18 
5’-TGATCTGTGCACGGAACTGAACAC-3’ 
5,-TCAACGGTTTCTGGCACCGCAG-3’ 
THERMOCYCLING 
The 0.2ml tubes having the positive and negative controls, endogenous 
control  and the sample are placed in the thermocycler and the programme has 
been set to run in the following steps 
1. Denaturation at 95*c for 30 seconds 
2. Annealing at 54*c for 30 seconds 
3. Primer extension  at 72*c for 30 seconds 
4. Again step 1, the cycle is repeated for 35 times. 
GEL ELECTROPHORESIS 
After the amplification cycles [35 cycles] are completed in the 
thermocycler, the tubes are taken out from the thermocycler and then 5µl of 
DNA ladder, 20µl of sample and 20µl negative, positive and endogenous 
controls, are loaded in to gel wells using micropipette. Electrical leads are 
connected to the electrophoresis tank. Current is supplied with a voltage of 150 
v so that negatively charged DNA migrate from cathode to anode. Gel running 
time is approximately the time taken by the gel loading dye to cover ¾ ths of 
distance in the gel. 
  
After the gel electrophoresis, PCR products are observed using UV 
transilluminator. The DNA ladder is a mixture of fragments with known size to 
compare with the PCR fragments. Amplicons of size 200bp and 300bp are 
consistent with HPV 16 E7 and HPV 18 E7 respectively and are taken as 
positive. 
                 
                                            
 
 
 
         
 
 
 
 
 
 
 
 
 
 
 
OBSERVATION AND RESULTS
 
Two hundred high risk subjects 
having sex with male 
women PRO W-24, and Transgenders
recruited and included in 
 
 Samples for HPV 16 & 18 viral isolation were taken according to the sexual 
habits of the patients and blood for serological testing for syphili
collected from all the patients after obtaining their consent for the same.
Specimens taken included pharyngeal, rectal, high vaginal, endocervical and 
urethral swabs. All the specimens were processed in the Department of 
Microbiology, at our institute. The results obtained were analysed. 
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AGE OF STUDY POPULATION
AGE 
IN 
YEARS 
FSW MSM
18-20 1 
(1.53%) 
3 
21-30 26 
(40%) (50%)
31-40 32 
(49.2%) (26.6%)
41-50 6 
(9.2%) (13.3%)
TOTAL 65 
 The overall commonest age group in this study population is 31
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- TABLE 1 
 PROM. 
MEN 
PROM. 
WOMEN 
TRANSGE
NDER 
(10%) 1 
(1.35%) 
1 
(4.16%) 
1 (14.2%) 
15 
 
26 
(35.1%) 
10 
(41.6%) 
4 (57.1%) 
8 
 
31 
(41.8%) 
12 (50%) 2 (28.5%) 
4 
 
16 
(21.6%) 
1 
(4.16%) 
0 (0%) 
30 74 24 7 
MSM PROM. MEN PROM. 
WOMEN
TRANSGENDER
AGE RANGE
-20 yrs 21-30 yrs 31-40 yrs 41-50 yrs
TOTAL 
7 
(3.5%) 
81 
(40.5%) 
85 
(42.5%) 
27 
(13.5%) 
200 
- 40 years. 
 
  
 
 
GENDER DISTRIBUTION
Married
72%
MARITAL STATUS
 
SEX 
MARITAL STATUS 
 
F M TG
Unmarried
29%
 
CATEGORY MARRIED
FSW 60
MSM 7
PROM. MEN 50
PROM. WOMEN 24
TRANSGENDER 1
TOTAL 142
Pearson chi- square test df 4 asymptotic sigma 0.0005 (p>0.01
significant) 
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TABLE 2 
MARITAL STATUS 
 UNMARRIED TOTAL
 (92.3%) 5 (7.6%) 65 
 (23.3%) 23 (76.6%) 30 
 (67.5%) 24 (32.4%) 74 
 (100%) 0 (0%) 24 
 (14.2%) 6 (85.7%) 7 
 (71%) 58 (29%) 200 
UNMARRIED
MARITAL STATUS
PROM. MEN PROM. WOMEN TRANSGENDER
 
statistically 
 
 TYPES FSW
HETEROSEX
UAL 
65
(100%)
HOMOSEXUA
L 
0
BISEXUAL 0
 
The commonest mode of sex among FSW, Promiscuou
heterosexual (81%). 
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MODE OF SEX-  TABLE 3 
 MSM PRO
M. 
MEN 
PROM. 
WOM
EN 
TRANSG
ENDER
 
 
0 74 
(100
%) 
24 
(100%) 
0 
 21 
(70%) 
0 0 7 (100%)
 9 
(30%) 
0 0 0 
s men and women is 
HOMOSEXUAL BISEXUAL
PROM. MEN PROM. WOMEN TRANSGENDER
 
TOTAL 
163 
(81.5%) 
 28 
(14%) 
9 (4.5%) 
 
  
CLASSIFICATION OF MALE SEX WITH MALE PATIENTS AND THEIR 
OBSERVED PREVALENCE 
Male sex workers [MSWs] are classified into different categories based 
on gender, Identity, behavior and profession. Based on identity they are 
categorized as ‘gay’, bisexuals , kothis –who are  ano receptive, oro receptive 
and both oro and ano receptive partners, Panthis- who are ano insertive, oro 
insertive and both ano and oro insertive and  Double deckers  who are both 
ano/oro receptive and insertive. 
TYPE  MSM TRANSGENDER TOTAL 
KOTHIS ORO RECEPTIVE 
(13.3%) 
4 0 4 
ANO RECEPTIVE 
(20%) 
6 0 6 
ANO/ ORO 
RECEPTIVE 
(26.6%) 
8 7 (100%) 15 
PANTHIS ORO INSERTIVE 
(16.6%) 
5 0 5 
ANO INSERTIVE 
(6.6%) 
2 0 2 
ORO ANO 
INSERTIVE (0%) 
0 0 0 
DOUBLE 
DECKERS 
ORO INS/ REC (0%) 0 0 0 
ANO INS/ REC 
(3.3%) 
1 0 1 
ORO ANO INS/ REC 
(13.3%) 
4 0 4 
TOTAL 30 7 37 
 
Among the MSMs in our study group the commonest group is ano/oro 
receptive [26.6%] Kothis and among the transgenders enrolled in our study the 
predominant mode of sexual contact is  ano/oro receptive [100%].     
OBSERVATION OF PROTECTED SEX
CATEGORY 
FSW 
MSM 
PROM. MEN 
PROM. WOMEN 
TRANSGENDER 
TOTAL 
Pearson chi- square test df 4 asymptotic 
statistically significant)
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- TABLE 5 
PROTECTED 
SEX 
UNPROTECTED 
SEX 
44 (67.6%) 21(32.4%) 
18 (60%) 12 (40%) 
21(28.3%) 53 (71.7%) 
16 (66.6%) 8 (33.4%) 
6 (85.7%) 1(14.3%) 
105 (52.5%) 95 (47.5%) 
sigma 0.0005 (p value 
 
MSM PROM. MEN PROM. WOMEN TRANSGENDER
PROTECTED SEX
PROTECTED SEX UNPROTECTED SEX
TOTAL 
65 
30 
74 
24 
7 
200 
<0.01 
 
CATEGORY PRIMARY 
SCHOOL 
( UPTO 8
GRADE)
FSW 50 (76.9%)
MSM 17 (56.6%)
PROM. MEN 34 (45.9%)
PROM. WOMEN 18 (75%)
TRANSGENDER 6 (85.7%)
TOTAL 125 (62.5%)
The educational status of the subjects 
primary level (62.5%). 
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EDUCATION STATUS 
TABLE 6 
 
TH
 
 
SEC. AND 
HIGHER 
SEC. 
SCHOOL(9th 
to 12th 
GRADE) 
COLLEGE 
(DIPLOMA/DEGREE)
 14 (21.5%) 1 (1.5%) 
 11 (36.6%) 2 (6.6%) 
 27 (36.4%) 13 (17.5%) 
 6 (25%) 0 (0%) 
 1 (14.3%) 0 (0%) 
 59 (29.5%) 16 (8%) 
in high risk group in predominantly 
MSM PROM. MEN PROM. 
WOMEN
TRANSGENDER
EDUCATION
Primary Sec. & HSc Dip./Degree
 
 
NATURE OF SPECIMENS COLLECTED
Category Pharyngeal 
swab
Fsw 1 
Msm 18 
Prom. Men 0 
Prom. Women 0 
Transgender 7 
Total 26 
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- TABLE 7
 
Rectal 
swab 
Endocervical 
swab 
High 
vaginal 
swab 
Urethral 
0 65 65 0
20 0 0 20
0 0 0 74
0 24 24 0
7 0 0 0
27 89 89 94
ENDOCERVICAL 
SWAB
HIGH VAGINAL 
SWAB
URETHRAL 
SWAB
PROM. MEN PROM. WOMEN TRANSGENDER
 
swab 
Blood 
sample 
 65 
 30 
 74 
 24 
 7 
 200 
 
BLOOD SAMPLE
  
High vaginal and endocervical swabs were collected from all the 65 female sex 
workers. Rectal and Pharyngeal swabs were collected from all 7 transgenders. 
Urethral swabs were collected from all the 74 promiscuous men and 
pharyngeal swab was collected from 10 promiscuous men and rectal swab was 
collected from 1 promiscuous man. Endocervical and high vaginal swabs were 
collected from all 24 promiscuous women. One pharyngeal swab was collected 
from a female sex worker who admitted of practicing oral sex. Blood was 
collected from all 200 patients for doing serological tests 
 
 
 
 
 
 
 
 
 
 
 
  
OTHER SEXUALLY TRANSMITTED ILLNESS FOUND IN THE STUDY 
POPULATION 
POSITIVITY IN DIRECT EXAMINATION- TABLE 8 
Tests 
Done 
Positive 
Findings 
High 
vaginal 
swab 
(89) 
Endocervical 
swab (89) 
Urethral 
swab 
(94) 
Rectal 
swab 
(27) 
Pharyngeal 
swab (26) Total 
Wet 
Mount 
(89) 
Clue cells 12 0 0 0 0 12 
Yeast cells 
with and 
without 
budding 
mycelium 
11 0 0 0 2 13 
Motile 
trichomonads 
3 0 0 0 0 3 
10% 
KOH 
mount 
Yeast cells 
with / without 
budding 
mycelium 
11 0 0 0 2 13 
Fishy odour/ 
amine test 
12 0 0 0 0 12 
Grams 
stain 
(325) 
Epithelial 
cells with 
lactobacillus 
59 0 0 0 0 59 
Clue cells 12 0 0 0 0 12 
Nugent 
score 
7- 10 
Lactobacillus 
1-4, <1 
12     12 
Mobiluncus 
>5, 1-4 
12     12 
Gardrenella 
5-30, >30 
12     12 
Pus cells and 
intracellular gram neg. 
diplococcic 
  3 2  5 
Yeast cells with/ 
without budding 
mycelium 
11    2 13 
 
 
  
Interpretation  
Motile, treponemes under dark ground illumination were observed in all 
10 cases of hard chancre. Multinucleated giant cells with faceted nuclei and 
homogenously stained ground glass chromatin (Tzanck cells) were observed in 
both cases of herpetic ulcers. 
Among the high vaginal swabs collected in FSW and promiscuous 
women, the wet mount showed clue cells in 12/89 (13.4%) which is in 
accordance with the gram stain. Yeast cells with and without budding 
mycelium was seen in  13/200 (6.5%) which is in accordance with 10% KOH 
mount and motile trichomonads were seen in 3/ 89 (3.37%) , Gram stain of the 
specimen collected showed pus cells and intracellular gram negative diplococci 
in 5/200 (2.5%).  The gram stain showed clue cells in 12/89 (13.4%) and 
Nugent16,20 score of 7 to 10 was seen in all 12 subjects 12/12 (100%).  
 
 
 
 
 
 
ASSOCIATED STI BY DIRECT EXAMINATION
POPULATION IN OUR STUDY GROUP (FSW AND PROMISCUOUS 
WOMEN) 
Category Trichomonas
Fsw (65) 2
Promiscuous 
women (24) 
1
89 3
 
 
 
TRICHOMONAS
BACTERIAL VAGINOSIS
VULVO VAGINAL CANDIDIASIS
GONORHOEA
GENITAL WART
 
 IN THE FEMALE 
TABLE 9 
 
Bacterial 
vaginosis 
Vulvo 
vaginal 
candidiasis 
Gonorrhoea
 8 8 0 
 4 3 0 
 12 11 0 
0 1 2 3 4 5 6
ASSOCIATED STI - Female
PROMISCUOUS WOMEN FSW
 
Genital 
wart 
2 
0 
2 
 
7 8 9
ASSOCIATED STI BY DIRECT EXAMINATION FOUND IN THE MALE 
POPULATION IN OUR STUDY GROUP (
AND PROMISCUOUS MEN) 
CATEGORY 
MSM (30) 
PROMISCUOUS 
MEN (74) 
104 
 
No associated STI was 
method. 
 
0
CANDIDIASIS
GONORRHOEA
GENITAL WART
 
MEN HAVING SEX WITH MEN 
 
TABLE 10 
CANDIDIASIS GONORRHOEA 
2 2 
0 3 
2 5 
identified in the transgender population in the direct 
1 2 3
ASSOCIATED STI - Male
PROMISCUOUS MEN MSM
GENITAL 
WART 
3 
0 
3 
 
4
GENITAL ULCER SYNDROME
CATEGORY 
FSW (65) 
MSM (30) 
PROMISCUOUS 
MEN (74) 
PROMISCUOUS 
WOMEN (24) 
TRANSGENDERS 
(7) 
TOTAL (200) 
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TABLE 11 
HERPETIC NON HERPETIC
SYPHILITIC 
0 1 
1 1 
1 6 
0 2 
0 0 
2 10 
MSM PROMISCUOUS 
MEN
PROMISCUOUS 
WOMEN
TRANSGENDERS
NON HERPETIC SYPHILITIC NON HERPETIC OTHERS
 
OTHERS 
0 
0 
0 
0 
0 
0 
 
CATEGORY 
FSW -  65 subjects 
MSM – 30 subjects 
Promiscuous men-  74 subjects
Promiscuous women- 24 subjects
Transgenders- 7 subjects 
 
Pearson chi- square test df 4 asymptotic sigma 0.01 (p value<0.05statistically 
significant) 
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TABLE 12 
ASSOCIATED STI PRESENT IN
21 subjects (32.3%) 
9 subjects (30%) 
 10 subjects ( 13.5%) 
 10 subjects (41.6%) 
0 (0%) 
MSM Promiscuous men Promiscuous 
women
 
TG
 TRICHOMONAS VAGINALIS WET MOUNT 
 T. VAGINALIS 
                                 
                           BACTERIAL VAGINOSIS- GRAM STAIN 
 
CANDIDA - BUDDING YEAST CELLS WITH PSEUDO HYPHAE 
                            
  
HERPES GENITALIS - TZANCK SMEAR OBSERVATION OF 
MULTINUCLEATED GIANT CELLS 
                         
 
 
GONOCOCCI - URETHRAL SMEAR GRAM STAIN 
                              
 
 
POSITIVITY IN SEROLOGICAL TESTS
TEST 
DONE 
FSW MSM
HIV 0 1 
RPR 1 1 
TPHA 1 1 
RPR- Pearson chi- square test df 4 
statistically significant)
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TABLE 13 
 PROM. 
MEN 
PROM. 
WOMEN 
TRANSGENDER
7 4 2 
12 4 2 
8 3 2 
asymptotic sigma 0.008 (p value <0.05 
 
MSM PROM. MEN PROM. WOMEN TRANSGENDER
HIV RPR TPHA
 TOTAL 
14 
20 
15 
HIV- Pearson chi- square test df 4 asymptotic sigma 0.005 (p value <0.05 
statistically significant)
 
 
 
 
 
 
 
 
 
 
 
 
NR
93%
REACTIVE
7%
HIV
 
  
PREVALENCE OF HPV 16 & 18 
HPV PCR test was conducted on the appropriate samples of all the 200 patients 
and the results were obtained as follows- 
THERMOCYCLER                           GEL ELECTROPHORESIS 
         
MULTIPLEX PCR FOR HPV 16 AND 18 
 
 
TABLE 14- PREVALENCE OF HPV 16 
CATEGORY HPV 16
FSW 2 
MSM 1 ( in kothis)
PROM. MEN 1 
PROM. WOMEN 1 
TRANSGENDER 0 
TOTAL 5 
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AND 18 BY PCR
 HPV 18 HPV 16 & 18
1 1 
 1 (in kothis) 0 
0 0 
0 0 
0 0 
2 1 
MSM PROM. MEN PROM. 
WOMEN
TRANSGENDER
HPV 16 HPV 18 HPV 16 & 18
 
 
 
COINFECTION IN HPV POSITIVES
TABLE 15- COINFECTION IN HPV POSITIVE SUBJECTS
 
HPV 
type 
 
FSW AND 
PROMISCUOUS WOMEN
 
BV 
 
TV
HPV 16 2 1 
HPV 18   
HPV 16 
AND 18 
  
 
 
 
0
0.5
1
1.5
2
2.5
BV
FSW AND PROMISCUOUS WOMEN
COINFECTION IN HPV POSITIVES 
 
 
 
 
 
MSM AND  
PROMISCUOUS MEN
 
 
CANDIDA 
 
CANDIDA 
 
GONORRHOEA
   
1 1  
   
TV CANDIDA CANDIDA
MSM AND 
PROMISCUOUS MEN
HPV 16 HPV 18
 
 
 
 
COINFECTION OF SYPHILIS, HIV AND HPV
Category FSW 
SYPHILIS 
& HIV 
0 
HPV 16&18  1 
HPV 16 & 
HIV 
0 
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- TABLE 16
MSM Promiscuous 
men 
Promiscuous 
women 
Trans
Gender
0 3 0 1 
0 0 0 0 
1 0 0 0 
MSM PROM. MEN PROM. WOMEN TRANSGENDER
COINFECTIONS
HPV 16&18  HPV 16 & HIV
 
 
 
Total 
4 
1 
1 
 
  
ASSOCIATION OF BLOOD TRANSFUSION AND IV DRUG ABUSE 
Blood transfusion history was present in a female sex worker and a 
promiscuous man. Intravenous drug abuse was present in 4 promiscuous men. 
All were HPV PCR negative. 
TABLE 17 
CATEGORY BLOOD 
TRANSFUSION 
IV DRUG ABUSE 
FSW 1 0 
MSM 0 0 
PROM. MEN 1 4 
PROM. WOMEN 0 0 
TRANSGENDER 0 0 
TOTAL 2 ( 0 HPV PCR) 4 ( 0 HPV PCR) 
 
 
 
 
 
 
  
DISCUSSION 
The prevalence of Human papilloma virus in our hospital was analysed 
in high risk groups in 200 subjects.  
The age group patterns are shown in Table 1. The commonest age 
observed in female sex workers is 31-40 years which is in concordance with 
the study of Pallavi Shukla et al22.  In our study the commonest age group 
among men having sex with men and transgenders was 21 to 30 years which is 
in concordance with studies of Abarna Devi et al23 and Dharma Nand Bhatta24. 
The commonest age group among promiscuous men and women who 
constituted the majority of the study population is 31 to 40 years which is in 
concordance with the studies conducted by Susan Walsh25. The overall 
commonest age group in our study population is 31 to 40 years. 
The Marital status among the study population is shown in Table 2. 
Majority of Female sex workers (92.3%) in our study group were married 
which is in concordance with studies of Hemalatha et al26. Men having sex with 
men and transgenders in our study group were mostly unmarried (76.6% and 
85.7%) which is in concordance with studies of HuyHa et al 27.Promiscuous  
men and women in our study group were married (67.5% and 100% 
respectively) which is in concordance with studies of Shilpi Choudhry et al28.  
The mode of sex (shown in Table 3) among female sex workers, 
Promiscuous men and women in our study group is Heterosexual mode which 
is in concordance with the studies of Abarna Devi et al.23 The mode of contact 
  
among men having sex with men(70%) and transgenders(100%) is homosexual 
while only 30% of men having sex with men were bisexual. This finding also 
coincides with the finding of Abarna Devi et al23.  
Among men having sex with men, the predominant mode of contact is 
ano/ oro receptive (kothis 26.6%) shown in Table 4. The sexual mode among 
transgenders is also ano/ oro receptive (100%). The above finding is in 
concordance with studies of Tanmay Mahapatra et al29. 
The last sexual contact (Table 5) among female sex workers, men 
having sex with men, Promiscuous men and women and transgenders was 
protected. This can be explained by the increasing female literacy rate, 
improved health care seeking behavior and awareness among the high risk 
groups30. The last sexual contact was predominantly unprotected (71%) among 
promiscuous men which is in concordance with the studies of Abarna Devi et 
al23. This is of health care significance as it constitutes a major reason for 
spread of sexually transmitted diseases. Health care providers must be taught of 
the significance of this issue with screening programmes to detect STI in this 
group.  
The educational status is shown in Table 6. 62% of our study population 
had completed only primary school education whereas 29% had completed 
secondary and higher secondary school education. Only 8% were 
diploma/degree holders. This observation was in concordance with studies of 
Solomon MM et al31.Commercial sex workers with lower educational level 
  
were afflicted more with sexually transmitted infections and participated in 
high risk behaviours. Majority of the female sex workers were among the 
primary school level in the study conducted by Melissa Sohoo et al2.  
The types of specimens collected in the study group is shown in table 7. 
As the mode of sexual contact among female sex workers and promiscuous 
women was heterosexual, high vaginal and endocervical swabs were taken 
from all the 65 female sex workers and 24 promiscuous women. As only one 
among the female sex workers admitted of practicing oral sex, a pharyngeal 
swab was also taken from her in addition. As the mode of contact among 
promiscuous men was heterosexual, urethral swabs were taken from them. 
Among the Male sex with male patients, swabs were taken according to their 
sexual habits. Rectal swabs for ano receptive, pharyngeal swabs for oro 
receptive and both from ano/ oro receptives were taken. Urethral swabs were 
taken for oro/ ano insertive MSM and all three swabs were taken from double 
deckers( ano/oro receptive/insertives). 7 out of 30 MSMs in our group reported 
bisexual mode of contact and hence urethral swabs were also taken from them 
in addition. The mode of contact among transgenders was ano/ oro receptive 
and hence rectal and pharyngeal swabs were taken from all 7 transgenders 
practicing commercial sex. Blood was collected from all 200 subjects for 
performing serological tests for HIV and Syphilis (RPR).  
The positivity in direct examination and the concominant STI in the 
male and female population in the high risk groups in our study population is 
shown in tables 8 to12. Associated sexually transmitted infections were found 
  
in 50 subjects (25%) of which 21 FSWs, 9 MSMs, 10 promiscuous men and 10 
promiscuous women. Positivity in direct examination was observed for 
Trichomoniasis, Bacterial Vaginosis, Candidiasis and Gonorrhoea. The 
prevalence of Trichomoniasis in our study group is 3.37% which is slightly 
higher when compared to the studies of Nimisha D Shethwala et al32 which is 
only 2%. The prevalence of Bacterial vaginosis in our study group was 13.4% 
which is in concordance with the study of Nimisha D Shethwala et al32 which 
was 13.3%.The prevalence of candidiasis in our study is 12.3% which is 
slightly higher than the study of Nimisha D Shethwala et al32 which is 
10.3%.The prevalence of Gonorrhoea in our study group was 4% which is less 
when compared to the study of Vandana et al33 which is 11%. 
Among the types of genital ulcers, there were 2 cases (1%) of herpetic 
ulcers and 10 cases (5%) of syphilitic ulcers. There were no other types of 
ulcers found. Genital warts was found in 5 cases (2.5%). As genital warts are 
caused by serotypes 6 and 11, these patients were also included for evaluating 
high risk HPV 16 and 18. 
Positivity in serological tests among the high risk groups is shown in 
table13. HIV was reactive among 7% of our study population. The prevalence 
of HIV was 0% among FSW, 3.3% among MSM. According to recent NACO 
statement, HIV prevalence among FSW and MSM are 2.67% and 4.43% 
respectively35. According to NACO, the prevalence of HIV among 
transgenders is between 17.5% to 41%35. In our study  the HIV prevalence 
among transgenders is 28.5%. HIV prevalence was 10.5% among promiscuous 
  
men and 12.5% among promiscuous women among our study.  Rapid plasma 
reagin test (RPR)  was reactive/ positive in for 1.5% in FSW, 3.3% in MSM 
and 28.5% in transgenders. Though the RPR was reactive in 20 subjects, TPHA 
was positive only in 15 subjects. This could be due to biological false positivity 
observed in RPR. The percentage among MSM in Pisani et al36 studies is 2%. 
The prevalence of syphilis in transgender is 13.6% in Brahman et al37 studies. 
The prevalence of syphilis among FSW in our study is low (1.5%) when 
compared to the studies of Uribe Salas (8.2%)38 
The prevalence of HPV 16 and 18 infection by PCR is shown in table 
14. HPV infection is mainly diagnosed by molecular methods since reliable 
serological tools are not available and culture of the virus is not possible. Since 
HPV cannot be propagated in tissue culture its accurate identification relies on 
molecular biology techniques. The PCR based techniques are highly sensitive, 
specific, reliable diagnostic tool for detecting targeted HPVs in tissue and 
cellular samples. Worldwide the most common HR-HPV (High risk- Human 
papilloma virus) are HPV 16/18 serotypes and are implicated in 70% of 
cervical cancers and 70% of anal cancers in men and 40-60 % of vulvar 
,vaginal and  penile cancers. 21. Hence type specific PCR to detect HPV 16/18 
serotypes was performed.  
Approximately 291 million women worldwide are HPV DNA carriers. 
32% of the HPV infected women from the general population are infected with 
High risk types 16 and 182. The median prevalence of high risk HPV by region 
was Africa (8%), America (11.1%), Eastern Mediterranean (13.7%), Europe 
  
(11.5%), South East Asia (13.9%), Western Pacific (6.9%). The prevalence of 
HPV type 16 ranged from 1.1% to 38.9% across all regions2. The most 
prevalent type reported among female sex workers included HPV 16 (38.9%) 
and HPV 18 (23.1%)2. In east Asia the most prevalent genotypes were HPV 16 
(23.9%) and HPV 18 (11%). 
In our study, the overall high risk HPV prevalence was 4% which is 
very low. HPV 16 was found in 2.5%, HPV 18 in 1% and HPV 16&18 in 
0.5%. The prevalence was among 4 female sex workers aged 20 to 30 years, 2 
MSMs aged 20 to 30 years, 1 promiscuous man aged 20 to 30 years and 1 
promiscuous woman aged 20 to 30 years.  HPV prevalence is high among 
younger age groups with increased sexual activity. The prevalence of HPV 
infection decreases with increasing age due to the clearance of infection and 
natural immunity and constant production of HPV systemic antibodies which 
contributes to an immune response against new infection4.  
FSWs have a 10 fold increased risk of HPV infection than the general 
population in the study by Peng RR et al39. In this study, a meta analytic 
approach to systematically analyse the literature to elucidate the prevalence and 
genotype distribution of cervical HPV infection among FSWs in Asia was done 
which showed a overall prevalence among FSWs to be 12.8% to 84.8%. The 
most prevalent genotypes were HPV 16(23.9%) and 18 (11%) in East Asia and 
HPV 52 (12.9%) and HPV 16 (8.5%) in south east Asia.  High risk HPV 
prevalence was 28% in Spaniards, 32% in Latin Americans and Eastern 
Europeans. The prevalence was 16% in sub-Saharan Africans and 16% in north 
  
Africans. High risk HPV 16 was the most common type detected 24% and 
HPV 18 was 11%40. In another study, overall HPV prevalence among FSW 
was 38.7% with high risk HPV 26.5% and HPV 16 was 8.3%41. 
 Studies have shown that having multiple sex partners may lead to 
higher HPV transmission. Hence female sex workers are at greater risk of 
infection when compared to the general population. Moreover HPV can be 
transmitted from FSW to the general population through clients thereby 
increasing the prevalence of the virus2. In our study, HPV prevalence among 
the FSWs was (4/65) i.e., 6.2%. This is low compared to results of many 
studies. The reason for a low HPV in FSW could be due to a 67.6% protected 
sex found in our study in this group. 
In our study the prevalence of HPV among MSM was 6.6% (HPV 16 
3.3% and HPV 18 3.3%). 1 MSM who was positive for HPV 16 was also HIV 
reactive. Anal canal is the common site in this group and anal cancer incidence 
is estimated to be 44 times higher than the general population. Among the 
MSM,  ano receptive intercourse is more prone for HPV infection. HIV 
infected MSM are at particularly high risk for anal HPV infection. Studies 
show that upto 95% HIV infected MSM also harbor anal HPV infection and 
their risk of anal cancer is 60 times higher than that of general population42. 
  HIV infection is a strong and independent determinant for HPV 
seropositivity due to the persistence of HPV infection in HIV infected MSM. 
Seroprevalence of high risk HPV 16 among HIV negative MSM was 37.1% 
  
whereas in HIV positive MSM it was 62.7%. Similarly sero prevalence of HPV 
18 was also high in MSM who were HIV positive (42.5%) when compared to 
MSM who were HIV negative (29.1%)43. In various studies conducted to detect 
the prevalence of HPV 16 and 18 in MSM the results were HPV 16 17%, HPV 
18 (32.5%)44. HPV 16 prevalence was 24.5%. In another study by Maria A 
Pando45, HPV 16 was the most common type detected among MSM and MSM 
& W and MSW( Male Sex Worker) and is responsible for most HPV 
associated penile cancers46. Penile high risk HPV prevalence was 16% in HIV 
negative and 32% in HIV positive MSM. Prevalence of anal high risk HPV 
prevalence was 45% in HIV negative and 65% in HIV positive MSM. HPV 16 
was detected in 22% of HIV positive MSM and 13% of HIV negative MSM47. 
Prevalence of anal canal HPV 16 was more than double among MSM when 
compared to heterosexual men (6.3%  and 2.2%)48. HPV 16 and 18 
seropositivity was high in ano receptive MSM when compared to insertive 
MSM47. In our study the prevalence is low (6.6%) when compared to many 
studies. In our study there was a 60% protected sex rate. This could have been 
the reason for low prevalence found in our study.  
Among the transgender population in our group, HPV 16 or 18 was not 
detected in any of the 7 subjects in our study. In a study conducted by Maria 
Sol Dos et al, the prevalence of HPV 16 and 18 was found to be 82.5% among 
transgenders.49. 
HPV 16 was identified in 1 out of 74 promiscuous men and 1 out of 24 
promiscuous women. Promiscuity is the practice of having casual sex 
  
frequently with different partners and being indiscriminate in the choice of 
sexual partners. In India sexual promiscuity is considered immoral, sinful and 
is a deviation from the acceptable moral standards. Along with modernization, 
attitude regarding sex are changing fast and promiscuity is on the increase 
indicating the weakening of the traditional familial and societal controls on 
sexual behavior50. Although there are no conclusive studies to show that 
promiscuous men and women have high HPV prevalence, it is important to 
screen this group as we found that it is the group with the highest incidence of 
unprotected sex. 
.  Coinfection of concomitant sexually transmitted infections in HPV 16 
and 18 positive subjects is shown in table 15. In our study population, 2 female 
sex workers positive for HPV-16 by PCR also had associated Bacterial 
vaginosis, and one female sex worker who was positive for HPV-16 also had 
associated Trichomoniasis. One Promiscuous male and one promiscuous 
female with HPV 18 positivity had associated Candidiasis. This finding is in 
accordance with the observation of C.Rodriguez et al8. Bacterial vaginosis 
associated organisms produce cytokines, inflammatory mediators and enzyme 
sialidases.  The enzymes destroy protective mucosal barriers and increase 
susceptibility to cervical HR-HPV infection by facilitating adherence, invasion 
and eventually incorporation of HPV activated oncogenes in to the genome of 
cells in the transformation zone. Abnormal vaginal microbiota may also be 
implicated in the maintenance of subclinical HR-HPV infection. Enzymes that 
are produced by anaerobic bacteria and are involved in the pathogenesis of 
  
Bacterial vaginosis can potentially alter immune signals and promote 
degradation of protective factors rendering women more susceptible to 
acquiring HR-HPV. The double stranded RNA of T.Vaginalis is associated 
with differential expression of enzymes which affect virulence and alter the 
history of various STI in particular HR-HPV. Hence patients with Bacterial 
vaginosis and Trichomoniasis is at significant risk of acquiring High risk 
HPV8. 
Coinfection of syphilis and HIV and HPV is shown in table 16. In our 
study the prevalence of coinfection between HIV and Syphilis among the high 
risk groups was 2% which is slightly higher than the prevalence observed in the 
studies of Yan Luo et al51 which is 1.5% and slightly lower than the prevalence 
observed in the study of Aritra Das et al52which is 2.6%. Coinfection of HIV 
and HPV in our study group is 0.5% among the 200 subjects (compared to the 
studies of Lei Gao et al53 which is 8.3%) but the percentage of HPV positivity 
in HIV positive MSM was 100%. The percentage of HPV positivity in HIV 
positive MSM was 65% in the studies of Alberts CJ et al54 and 62.7% in the 
studies of Mooji SH et al.47 
History of blood transfusion was found in 2 subjects but they were not 
positive for any serological test and they did not have any associated illness 
(table 17). Intravenous drug abuse history is correlated with increased HPV 
infection due to high risk behaviour55. In our study IV drug abuse was present 
in 4 promiscuous men but were negative for HPV PCR. 
  
                                        SUMMARY 
 Out of 200 subjects in this prospective study, Promiscuous men and 
Female sex workers form the majority. 
 The common age group was  31- 40 years 
 Most of the subjects were married (71%) except MSM and 
Transgender population. 
 The mode of sex among the study group was heterosexual (81.5%). 
 Among the men having sex with men, the common type of sex was 
oro ano receptive (26.6%) kothis, followed by ano receptive (20%). 
 The last sexual contact was protected in 52.5% of the subjects. 
 62.5% of the subjects had only primary level of education. 
 Concomitant sexually transmitted illnesses were present in 25% (50 
out of 200) subjects. 
 Candidiasis was found in13, Bacterial vaginosis in 12, Syphilitic ulcer 
in 10, Gonorrhoea in 5, Genital warts in 5 and Trichomoniasis in 3 and 
Herpetic ulcer in 2 of the 50 subjects positive for other STIs. 
 In serological evaluation, HIV was reactive in 14, RPR in 20 and 
TPHA in 15 subjects. 
 HPV 16 and 18 was positive in 8 subjects by PCR. HPV 16 was 
positive in 5, HPV 18 in 2 and HPV 16 and 18 in 1 subject. 
  
 Coinfection in HPV positive subjects with other STIs was present in 5 
subjects (Bacterial vaginosis in 2, Candidiasis in2 and Trichomoniasis 
in 1 out of the 8 HPV positives) 
 Coinfection of HPV 16 and 18 was observed in 1 subject in1, HPV 16 
and HIV in 1 and HIV and syphilis in 4 subjects. 
 Blood transfusion and IV drug abuse was observed in 2 and 4 subjects 
respectively. No HPV positives were found in this group. 
 
 
 
 
 
 
 
 
 
 
 
 
  
                                        CONCLUSION  
 The study on the prevalence of Human Papilloma Virus in high risk 
group subjects was done in a total of 200 subjects comprising 65 female 
sex workers, 30 men having sex with men, 74 promiscuous men, 24 
promiscuous women and 7 transgenders attending STD clinic in our 
institution between September 2014 to September 2015.  
 As the presence of concomitant sexually transmitted infections increase 
the risk of acquisition of HR- HPV 16 and 18, they were also identified 
as a part of the study. 
 The HPV 16 & 18 PCR analysis of 200 anogenital and pharyngeal 
swabs detected 8 HPV positives which included 5 HPV16, 2 HPV18 and 
1 HPV 16 & 18. 
 Candidiasis was found in 13(26%),  Bacterial vaginosis in 12 (24%), 
Syphilitic ulcer in 10 (20%), Gonorrhoea in 5 (10%), Genital warts in 
5(10%) and Trichomoniasis in 3 (6%),  Herpetic ulcer in 2 (4%) of the 
50 positive for other STIs. 
 High risk HPV 16 and 18 serotypes are associated with anogenital and 
head and neck cancers. The high risk group can have asymptomatic 
infection and can transmit the infection to the general population 
through their clients. Hence regular screening of this high risk groups 
for HPV is essential. 
  
  HPV vaccine which targets HPV 16 and 18, the most common 
oncogenic types, is recommended to protect this high risk group from 
aggressive cancers of the anogenital region. 
  HPV vaccine induces a protective host immune response which is 
stronger and long lasting and includes partial cross protection against 
non vaccine related serotypes.    
 Education about safer sexual practices, regular screening for Sexually 
transmitted infections and prophylactic HPV vaccination in this high 
risk groups will protect the individuals and also prevent the transmission 
of infection to the general population..     
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PROFORMA 
Sl No: 
STD No: 
Name: 
Age: 
Sex: M/ F/ TG 
Marital status- Married (Y)/ unmarried (N) 
Education: primary/ secondary/ college 
Category: FSW/ MSM/ Promiscuous man/ Promiscuous woman/ Transgender 
Mode of sex: Heterosexual/ Homosexual/ Bisexual 
History of exposure: Extramarital (EMC)/ Premarital (PMC) 
Last Marital contact: 
Protected or Unprotected sex: Y/N 
History of associated STI  
History of Blood transfusion/ IV drug abuse/ Surgery 
Examination findings: ulcer/ discharge/ wart 
Types of swabs: high vaginal/ endocervical/ urethral/ rectal/ pharyngeal 
Serology: RPR/ HIV 
 
 
 
 
Sl. 
no 
Std  
no. 
sex age M  
Status 
Y/N 
edu Fsw MSM
/ 
Csw 
Pro. 
 M 
Pro.  
W 
LMC EMC PMC route Prot 
 sex 
Blood  
Trans/ 
 ivd 
Asso.  
Std 
        Nature of specimen RPR           HIV hpv 
pcr 
phar
y 
rect End 
cx 
Hi 
Vag 
ure   
1 320/15 M 19 N 10 std NA YES NA NA NA NA YES ANO REC NO NO YES NO YES NO NO NO NR NR  
2 334/15 M 30 Y BA., NA NO YES NA 7 DAYS YES YES HETERO NO NO NO NO NO NO NO YES NR NR  
3 547/15 M 24 N 9 std NA YES NA NA NA NO YES ORO REC YES NO NO YES NO NO NO NO NR NR  
4 546/15 M 27 N 10 std NA YES NA NA NA NA YES ORO ANO 
REC 
YES NO NO YES YES NO NO NO NR REACTIVE 16 
5 538/15 M 32 Y 8 std NA YES NA NA 4 YRS YES NO ORO ANO 
REC & BISEX 
YES NO NO YES YES NO NO YES NR NR  
6 539/15 M 29 N 7 std NA YES NA NA NA NA YES ORO REC YES NO NO YES NO NO NO NO NR NR  
7 542/15 M 36 N 12 std NA YES NA NA NA NA YES ORO INS YES NO NO NO NO NO NO YES NR NR  
8 550/15 M 32 Y 8 std NA YES NA NA 7 DAYS YES NO ANO ORO 
REC & BISEX 
YES NO YES YES YES NO NO YES NR NR 18 
9 549/15 M 48 Y 5 std NA YES NA NA 10 DAYS YES NO ANO ORO 
REC & BISEX 
YES NO NO YES YES NO NO YES NR NR  
10 447/15 F 29 Y 8 std YES NA NA NA 2 DAYS YES NO HETERO NO NO YES NO NO YES YES NO N R NR  
11 446/15 F 35 Y 6 std YES NA NA NA 1 DAY YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
12 443/15 F 33 Y 7 std YES NA NA NA 2 DAY YES NO HETERO NO NO YES NO NO YES YES NO NR NR  
13 442/15 F 33 Y 8 std YES NA NA NA 10 DAYS YES NO HETERO YES NO YES NO NO YES YES NO NR NR  
14 418/15 F 35 Y 9 std YES NA NA NA 1 DAY YES NO HETERO YES NO YES NO NO YES YES NO NR NR  
15 433/15 F 31 Y 7 std YES NA NA NA 2 WEEKS YES NO HETERO YES NO YES NO NO YES YES NO NR NR  
16 437/15 F 38 Y 10 std YES NA NA NA 1 WEEK YES NO HETERO YES NO YES NO NO YES YES NO NR NR  
17 506/14 F 32 Y 5 std NO NA NA YES 5 DAYS YES NO HETERO YES NO NO NO NO YES YES NO NR REACTIVE  
18 426/15 F 30 Y 7 std NA NA NA YES 1 DAY YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
19 425/15 F 34 Y 4 std NA NA NA YES 1 WEEK YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
20 573/14 F 27 Y 6 std NA NA NA YES 1 DAY YES NO HETERO YES NO YES NO NO YES YES NO NR NR 16 
21 427/15 F 26 Y 2 std NA NA NA YES 1 DAY YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
22 902/15 F 23 Y 10 std NA NA NA YES 1 DAY YES NO HETERO NO NO NO NO NO YES YES NO NR NR  
23 932/15  F 36 Y 8 std NA NA NA YES 2 
MONTHS 
YES NO HETERO NO NO NO NO NO YES YES NO NR NR  
24 817/15 F 36 Y 10 std NA NA NA YES 2 DAYS YES NO HETERO NO NO NO NO NO YES YES NO NR NR  
25 971/15 F 30 Y 12 std NA NA NA YES 4 DAYS YES NO HETERO YES NO YES NO NO YES YES NO NR NR  
26 871/14 F 40 Y 8 std NA NA NA YES 3 YEARS YES NO HETERO YES NO YES NO NO YES YES NO NR REACTIVE  
27 1264/ 15 M 19 N 7 std NA YES NA NA NA NA YES ANO REC NO NO YES NO YES NO NO YES NR NR  
28 1451/ 15 M 25 N 8 std NA YES NA NA NA NA YES ORO ANO 
REC 
YES NO NO YES YES NO NO NO NR NR  
29 1452/ 15 M 19 N 12 std NA YES NA NA NA NA YES ORO ANO 
REC 
YES NO YES YES YES NO NO NO NR NR  
30 660/ 15 M 23 y mphil NA NA YES NA 4 DAYS NO YES HETERO NO NO YES NO NO NO NO YES REACTIV
E 
NR  
31 688/ 15 M 42 Y 8 std NA NO YES NA 4 DAYS YES NO HETERO NO NO YES NO NO NO NO YES REACTIV
E 
NR  
32 1421/ 15 M 23 N 10 std NA NO YES NA NA NA YES HETERO YES NO YES NO NO NO NO YES REACTIV
E 
NR  
33 1599/ 15 M 42 Y 12 std NA NO YES NA 2 
MONTHS 
YES NO HETERO YES NO NO NO NO NO NO YES NR NR  
34 617/ 15 M 42 Y 5 std NA NO YES NA 1 WEEK NO YES HETERO YES NO NO NO NO NO NO YES NR NR  
35 1502/ 15 M 34 N 10 std NA NO YES NA NA NO YES HETERO YES NO NO NO NO NO NO YES REACTIV
E 
NR  
36 1503/ 15 M 39 Y 10 std NA NA YES NA 2 WEEKS YES NO HETERO YES NO NO NO NO NO NO YES NR NR  
37 1380/ 14 M 20 N 5 std NA NA YES NA 2 DAYS NO YES HETERO NO NO YES NO NO NO NO YES NR REACTIVE  
38 1202/ 
15 
M 30 Y 10 std NA NA YES NA 1 WEEK YES YES HETERO NO NO YES NO NO NO NO YES REACTIV
E 
NR  
39 1499/ 15 M 38 Y iti NA NA YES NA 5 DAYS YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
40 1495/ 15 M 46 Y 12 std  NA YES NO NA 1 WEEK YES NO ANO ORO 
REC & BISEX 
YES NO NO YES YES NO NO YES NR NR  
41 1494/ 15 M 25 N 10 std NA YES NO NA NA NA YES ORO REC YES NO NO YES NO NO NO NO NR NR  
42 1627/ 15 M 35 N 7 std NA YES NO NA NA NA YES ANO REC YES NO NO NO YES NO NO NO NR NR  
43 444/15 F 27 Y  10 std YES NA NA NO 2 DAYS YES NO HETERO YES NO YES NO NO YES YES NO NR NR 16 
44 441/15 F 39 Y 3 std YES NA NA NO 1 WEEK YES NO HETERO NO NO NO NO NO YES YES NO NR NR  
45 440/15 F 35 Y 2 std YES NA NA NO 5 DAYS YES NO HETERO NO NO NO NO NO YES YES NO NR NR  
46 439/15 F 40 Y 4 std YES NA NA NO 3 DAYS YES NO HETERO NO NO NO NO NO YES YES NO NR NR  
47 471/15 F 41 Y 5 std YES NA NA NO 8 DAYS YES NO HETERO YES NO YES NO NO YES YES NO REACTIV
E 
NR  
48 540/15 F 35 Y 3 std NO NA NA YES 4 DAYS YES YES HETERO YES NO YES NO NO YES YES NO REACTIV
E 
NR  
49 432/15 F 40 Y 4 std NO NA NA YES 4 DAYS YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
50 431/15 F 36 Y 8 std NO NA NA YES 2 
MONTHS 
YES NO HETERO YES NO NO NO NO YES YES NO NR REACTIVE  
51 430/15 F 40 Y  5 std NO NA NA YES 1 WEEK YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
52 524/15 F 25 Y 3 std NO NA NA YES 1 WEEK YES NO HETERO YES NO YES NO NO YES YES NO REACTIV
E 
NR  
53 1213/ 15 F 36 Y 8 std NO NA NA YES 1 MONTH YES NO HETERO NO NO NO NO NO YES YES NO NR NR  
54 424/15 F 26 Y 10 std YES NA NA NO 1 MONTH YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
55 1629/ 15 F 42 Y 7 std YES NA NA NO 10 DAYS YES NO HETERO NO NO YES NO NO YES YES NO NR NR  
56 1214/ 15 F 35 Y 4 std YES NA NA NO 20 DAYS YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
57 1216/ 15 F 34 Y 8 std YES NA NA NO 1 WEEK YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
58 1219/ 15 F 24 Y 5 std YES NA NA NO 1 MONTH YES NO HETERO YES NO YES NO NO YES YES NO NR NR 18 
59 1220/ 15 F 26 Y 9 std YES NA NA NO 3 DAYS YES NO HETERO NO NO NO NO NO YES YES NO NR NR  
60 1221/ 15 F 29 N 6 std YES NA NA NO NA NA YES HETERO NO NO NO NO NO YES YES NO NR NR  
61 1217/ 15 F 30 Y 2 std YES NA NA NO 1 MONTH YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
62 1222/ 
15 
F 35 Y 2 std YES NA NA NO 2 WEEKS YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
63 1218/ 15 F 30 Y 3 std YES NA NA NO 1 MONTH YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
64 1583/  15 M 25 N 10 std NA YES NO NA NA NA YES ANO ORO 
REC INS 
NO NO YES YES YES NO NO YES NR NR  
65 1556/ 15 M 44 Y 7 std NA YES NO NA 2 WEEKS YES NO ORO INS & 
BISEX 
YES NO NO YES NO NO NO YES NR NR  
66 1661/ 15 M 21 N BE NA YES NO NA NA NA YES ANO ORO 
REC 
NO NO NO YES YES NO NO NO NR NR  
67 367/15 M 30 N 2 std NA YES NO NA NA NA YES ORO ANO 
REC INS  
NO NO NO YES YES NO NO YES NR NR  
68 391/ 15 M 35 N 10 std NA NO YES NA NA NA YES HETERO YES NO YES NO NO NO NO YES REACTIV
E 
NR  
69 190/ 15 M 38 N 8 std NA NO YES NA NA NA YES HETERO YES NO NO NO NO NO NO YES REACTIV
E 
NR  
70 1559/ 15 M 28 Y Deg NA NO YES NA 3 
MONTHS 
YES NO HETERO YES NO NO NO NO NO NO YES NR NR  
71 1557/ 15 M 37 N 5 std NA NO YES NA NA NA YES HETERO NO NO NO NO NO NO NO YES NR NR  
72 1555/ 15 F 31 N 4 std YES NO NO NO NA NA YES HETERO NO NO YES NO NO NO NO YES NR NR  
73 1139/ 14 M 43 Y 4 std NA NO YES NA 3 DAYS YES NO HETERO NO NO NO NO NO NO NO YES NR REACTIVE  
74 1550/ 15 M 39 Y 12 std NA NO YES NA 4 DAYS YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
75 1551/ 15 M 48 Y 3 std NA NO YES NA 3 WEEKS YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
76 1539/ 15 M 28 N 8 std NA NO YES NA NA NA YES HETERO YES NO NO NO NO NO NO YES NR NR  
77 1437/ 
14 
M 31 N ITI NA NO YES NA NA NA YES HETERO YES NO NO NO NO NO NO YES NR REACTIVE  
78 1105/ 14 M 23 Y 6 std NA NO YES NA 1 WEEK YES NO HETERO NO NO NO NO NO NO NO YES NR NR 16 
79 1588/ 15 M 28 Y 12 std NA NO YES NA 2 DAYS YES NO HETERO YES NO NO NO NO NO NO YES NR NR  
80 1671/ 15 M 40 Y 7 std NA NO YES NA 1 DAY YES NO HETERO NO IVD NO NO NO NO NO YES NR NR  
81 1670/ 15 M 40 Y 11 std NA NO YES NA 10 DAYS YES NO HETERO NO IVD NO NO NO NO NO YES NR NR  
82 52/15 M 28 Y BA NA NO YES NA 3 DAYS YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
83 1247/ 15 F 21 Y 8 std YES NA NA NO 2 
MONTHS 
YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
84 1246/ 15 F 28 Y 10 std YES NA NA NO 3 DAYS YES NO HETERO YES NO YES NO NO YES YES NO NR NR  
85 263/15 F 35 Y 9 std YES NA NA NO 1 WEEK YES NO HETERO YES NO NO NO NO YES YES MO NR NR  
86 357/15 F 31 Y 6 std YES NA NA NO 1 WEEK YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
87 299/15 F 31 Y  10 std YES NA NA NO 5 DAYS YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
88 298/15 F 31 Y 10 std YES NA NA NO 1 WEEK YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
89 283/15 F 24 Y 5 std YES NA NA NO 1 WEEK YES NO HETERO YES NO YES NO NO YES YES NO NR NR  
90 282/15 F 25 Y 3 std YES NA NA NO 2 WEEKS YES NO HETERO NO NO YES NO NO YES YES NO NR NR  
91 1158/ 15 F 33 Y 10 std NO NA NA YES 1 DAY YES NO HETERO YES NO YES NO NO YES YES NO NR NR  
92 308/15 F 26 Y 7 std NO NA NA YES 1 WEEK YES NO HETERO YES NO YES NO NO YES YES NO NR NR  
93 35/15 F 30 Y 3 std NO NA NA YES 4 DAYS NO YES HETERO NO NO YES NO NO YES YES NO NR NR  
94 423/15 F 40 Y 10 std NO NA NA YES 10 DAYS YES NO HETERO NO NO NO NO NO YES YES NO NR NR  
95 281/15 F 30 Y 2 std YES NA NA NO 2 WEEKS YES NO HETERO NO NO NO NO NO YES YES NO NR NR  
96 422/15 F 38 Y 10 std YES NA NA NO 1 MONTH YES NO HETERO/ 
ORAL 
NO NO NO YES NO YES YES NO NR NR  
97 421/15 F 38 Y 5 std YES NA NA NO 1 MONTH YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
98 303/15 F 27 Y 6 std YES NA NA NO 1.5 
MONTH 
YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
99 304/15 F 37 Y 7 std YES NA NA NO 4 
MONTHS 
YES NO HETREO YES NO NO NO NO YES YES NO NR NR  
100 305/15 F 36 Y 4 std YES NA NA NO 4 
MONTHS 
YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
101 306/15 F 30 Y 2 std YES NA NA NO 3 
MONTHS 
YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
102 284/15 F 24 Y 4 std YES NA NA NO 2 
MONTHS 
YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
103 285/15 F 35 Y 3 std YES NA NA NO 2 WEEKS YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
104 286/15 F 40 Y 7 std YES NA NA NO 1 WEEK YES NO HETERO NO NO NO NO NO YES YES NO NR NR  
105 287/15 F 40 Y 5 std YES NA NA NO 15 DAYS YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
106 288/15 F 27 Y 7 std YES NA NA NO 1 WEEK YES NO HETERO YES YES NO NO NO YES YES NO NR NR  
107 289/15 F 35 Y 3 std YES NA NA NO 10 DAYS YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
108 290/15 F 31 Y 9 std YES NA NA NO 4 DAYS YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
109 291/15 F 35 Y 7 std YES NA NA NO 1 MONTH YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
110 292/15 F 25 N 10 std YES NA NA NO NA NA YES HETERO YES NO NO NO NO YES YES NO NR NR  
111 293/15 F 27 Y 4 std YES NA NA NO 3 DAYS YES NO HETERO YES NO NO NO NO YES YES NO NR NR 16 
18 
112 294/15 F 30 Y 5 std YES NA NA  NO 1 WEEK YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
113 295/15 F  35 Y 6 std YES NA NA NO 1 WEEK YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
114 1687/ 15 M 28 Y 11 std NA NO YES NA 1 WEEK YES NO HETERO NO NO NO NO NO NO NO YES REACTIV
E 
NR  
115 1259/ 15 F 20 Y 10 std NO NA NA YES 1 WEEK YES NO HETERO NO NO YES NO NO YES YES NO REACTIV
E 
NR  
116 1694/ 15 M 37 Y 11 std NA NO YES NA 2 DAYS YES NO HETERO YES YES NO NO NO NO NO YES NR NR  
117 1578/ 15 M 27 N 5 std NA NA YES NA NA NO YES HETERO NO NO NO NO NO NO NO YES NR NR  
118 1838/ 15 M 34 Y 7 std NA YES NO NA 4 DAYS YES NO ANO INS & 
BISEX 
NO NO NO NO NO NO NO YES NR NR  
119 1665/ 
15 
M 34 Y 9 std NA NO YES NA 1 WEEK YES NO HETERO YES NO NO NO NO NO NO YES NR NR  
120 1854/ 15 M 45 N 8 std NA YES NO NA NA NA YES ANO REC & 
BISEX 
YES NO NO NO YES NO NO YES NR NR  
121 290/15 M  24 N 8 std NA YES NO NA NA NA YES ORO ANO –
REC & INS 
NO NO YES YES YES NO NO YES NR NR  
122 1810/ 15 M 27 N mba NA NO YES NA NA NA YES HETERO NO NO NO NO NO NO NO YES NR NR  
123 1748/ 15 M 44 Y 7 std NA NO YES NA 5 DAYS YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
124 1849/ 15 M 32 Y 12 std NA NO YES NA 10 DAYS YES NO HETREO NO NO NO NO NO NO NO YES NR NR  
125 560/15 M 38 Y 10 std NA NO YES NA 1 WEEK YES NO HETERO YES NO NO NO NO NO NO YES NR NR  
126 1388/ 15 F 18 N 9 std YES NA NA NA NA NA YES HETERO NO NO YES NO NO YES YES NO NR NR 16 
127 1853/ 15 F 40 Y iti YES NO NO NA 10 DAYS YES NO HETERO YES NO NO NO NO NO NO YES NR NR  
128 1850/ 15 F 28 N 7 std YES NO NO NA NA NA YES HETERO YES NO NO NO NO NO NO YES NR NR  
129 1786/ 15 M 28 Y 5 std NA NO YES NA 10 DAYS YES NO HETERO YES NO NO NO NO NO NO YES NR NR  
130 1861/ 
15 
M 30 N 6 std NA YES NO NA NA NA YES ANO REC & 
BISEX 
YES NO YES NO YES NO NO YES NR NR  
131 1355/ 
15 
M 44 Y 8 std NA NO YES NA 1 MONTH YES NO HETERO NO NO NO NO NO NO NO YES REACTIV
E 
NR  
132 1858/ 15 M 24 N BE NA NO YES NA NA NA YES HETERO YES NO NO NO NO NO NO YES NR NR  
133 1716/ 15 M 39 Y 10 std NA NO YES NA 4 WEEKS YES NO HETERO YES NO NO NO NO NO NO YES NR NR  
134 1860/ 15 M 24 N B com NA NO YES NA NA NO YES HETERO YES NO NO NO NO NO NO YES NR NR  
135 1804/ 
15 
M 34 Y 9 std NA NO YES NA NO NO YES HETERO NO NO NO NO NO NO NO YES NR REACTIVE  
136 549/ 15 F 47 Y 8 std NO NA NA YES NO YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
137 1397/ 15 F 28 Y 4 std YES NA NA NO 1DAY YES NO HETERO NO NO NO NO NO YES YES NO NR NR  
138 1398/ 15 F 34 y  8 std YES NA NA NO 1 WEEK YES NO HETERO NO NO NO NO NO YES YES NO NR NR  
139 1399/ 15 F 43 Y 7 std YES NA NA NO 10 DAYS YES NO HETERO NO NO NO NO NO YES YES NO NR NR  
140 1400/ 15 F 42 Y 6 std YES NA NA NO 1 WEEK YES NO HETERO YES NO YES NO NO YES YES NO NR NR  
141 1401/ 15 F 36 Y 5 std YES NA NA NO 2 WEEKS YES NO HETERO NO NO YES NO NO YES YES NO NR NR  
142 1402/ 
15 
F 35 Y 4 std YES NA NA NO 1 WEEK YES NO HETERO YES NO NO NO NO YES YES NO NR NR  
143 74/14 F 26 Y 2 std NO NA NA YES 15 DAYS YES NO HETERO YES NO YES NO NO YES YES NO REACTIV
E 
REACTIVE  
144 1043/ 15 F 27 Y 6 std NO NA NA YES 1 WEEK YES NO HETERO NO NO NO NO NO YES YES YES NR NR  
145 1447/ 14 M 25 N Deg NA NO YES NA NA NO YES HETERO YES NO YES NO NO NO NO YES REACTIV
E 
REACTIVE  
146 1905/ 15 M 24 Y Dip NA NO YES NA 1 WEEK YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
147 1324/ 14 M 35 N 6 std NA NO YES NA NA NO YES HETERO NO NO YES NO NO NO NO YES REACTIV
E 
REACTIVE  
148 1918/ 15 M 34 N 10 std NA NO YES NA NA NA YES HETERO NO NO NO NO NO NO NO YES NR NR  
149 1919/ 20 M 34 N 10 std NA NO YES NA NA NA YES HETERO NO NO NO NO NO NO NO YES NR NR  
150 1866/ 
15 
M 21 N 12 std NA NO YES NA NA NA YES HETERO NO NO NO NO NO NO NO YES NR NR  
151 1920/ 15 M 30 N 10 std NA YES NO NA NA NA YES ANO ORO INS 
REC 
NO NO NO YES YES NO NO YES NR NR  
152 1567/ 15 M 29 N BA NA YES NO NA NA NA YES ORO INS NO NO YES YES YES NO NO YES REACTIV
E 
NR  
153 1923/ 15 M 26 Y 8 std NA NO YES NA 1 MONTH NO YES HETERO NO NO NO NO NO NO NO YES NR NR  
154 1924/ 15 M 42 Y 10 std NA NO YES NA 20 DAYS YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
155 1926/ 15 M 30 Y 12 std NA NO YES NA 6 WEEKS YES NO HETERO YES NO NO NO NO NO NO YES NR NR  
156 1925/ 
15 
M 36 N 10 std NA YES NO NA NA NA YES ANO INS YES NO NO NO NO NO NO YES NR NR  
157 1935/ 
15 
M 30 N 8 std NA YES NO NA NA NA YES ANO REC YES NO NO NO YES NO NO NO NR NR  
158 1929/ 15 M 36 Y 10 std NA NO YES NA 1 WEEK YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
159 1934/ 15 M 25 N Dip NA NO YES NA NA NO YES HETERO NO NO NO NO NO NO NO YES NR NR  
160 1933/ 15 M 47 Y 4 std NA NO YES NA 5 DAYS YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
161 1936/ 15 M 23 N 6 std NA NO YES NA NA NO YES HETERO NO NO NO NO NO NO NO YES NR NR  
162 1958/ 15 M 40 Y 8 std NA NO YES NA 1 WEEK YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
163 1963/ 15 M 34 Y 12 std NA NO YES NA 3 WEEKS YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
164 1904/ 15 M 35 N 10 Std NA NO YES NA NA NO YES HETERO NO NO NO NO NO NO NO YES NR NR  
165 1957/ 15 M 43 Y 10 std NA NO YES NA 4 DAYS YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
166 1965/ 15 M 35 Y 7 std NA NO YES NA 1 WEEK YES NO HETERO NO NO NO NO NO NO NO YES NR REACTIVE  
167 1956/ 15 M 47 Y 6 std NA NO YES NA 4 WEEKS YES NO HETERO NO NO YES NO NO NO NO YES NR NR  
168 1953/ 15 M 46 Y Iti NA NO YES NA 5 DAYS YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
169 184/ 15 M 38 Y 10 std NA NO YES NA 4 DAYS YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
170 1439/  15 F 49 Y 6 std YES NA NO NO 1 WEEK YES NO HETERO NO NO NO NO NO YES YES NO NR NR  
171 1441/ 15 F 26 Y 4 std YES NA NO NO 5 DAYS YES NO HETERO YES NO YES NO NO YES YES NO NR NR  
172 1442/ 15 F 26 Y 8 std YES NA NO NO 2 DAYS YES NO HETERO NO NO YES NO NO YES YES NO NR NR  
173 1443/ 15 F 41 Y 5 std YES NA NO NO 3 WEEKS YES NO HETERO NO NO NO NO NO YES YES NO NR NEG  
174 1440/ 15 F 30 Y 7 std YES NA NO NO 2 WEEKS YES NO HETERO YES NO YES NO NO YES YES NO NR NEG  
175 1276/ 15 F 30 Y 10 std YES NA NO NO 1 DAY YES NO HETERO YES NO YES NO NO YES YES NO NR NEG  
176 1818/ 15 M 32 N 5 std NA YES NO NA NA NA YES ORO INS NO NO NO NO NO NO NO YES NR NEG  
177 1757/ 15 M 26 N 7 std NA YES NO NA NA NA YES ANO REC & 
INS 
YES NO YES NO YES NO NO YES NR NEG  
178 1758/ 15 M 22 N 10 std NA YES NO NA NA NA YES ORO  INS YES NO NO NO NO NO NO YES NR NEG  
179 1676/ 15 M 32 Y 8 std NA YES NO NA 1 WEEK YES NO ORO REC & 
BISEX 
NO NO NO YES NO NO NO YES NR NR  
180 1863/ 15 TG 28 N 8 std CSW NA NA N0 NA NA YES ORO ANO 
REC 
YES NO NO YES YES NO NO NO NR NR  
181 14/ 15 TG 25 N 3 std CSW NA NA NO NA NA YES ORO ANO 
REC 
YES NO NO YES YES NO NO NO NR NR  
182 4/ 15 TG 30 N 5 std CSW NA NA NO NA NA YES ORO ANO 
REC 
YES NO NO YES YES NO NO NO NR NR  
183 5/15 TG 20 N 7 std CSW NA NA NO NA NA YES ORO ANO 
REC 
YES NO NO YES YES NO NO NO REACTIV
E 
NR  
184 6/ 15 TG 24 N 9 std CSW NA NA NO NA NA YES ORO ANO 
REC 
YES NO NO YES YES NO NO NO REACTIV
E 
REACTIVE  
185 932/ 14 TG 31 N 6 std CSW NA NA NO NA NA YES ORO ANO 
REC 
NO NO NO YES YES NO NO NO NR REACTIVE  
186 8/ 15 TG 40 Y 3 std CSW NA NA NO NA NA YES ORO ANO 
REC 
YES NO NO YES YES NO NO NO NR NR  
187 1832/ 15 M 45 Y 5 std NA NO YES NA 1 WEEK YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
188 1821/ 15 M 36 Y 4 std NA NO YES NA 3 DAYS YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
189 1946/ 15 M 30 Y 2 std NA NO YES NA 2 DAYS YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
190 1945/ 15 M 35 Y 8 std NA NO YES NA 2 WEEKS YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
191 1809/ 15 M 46 Y 3 std NA NO YES NA 4 DAYS YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
192 1792/ 15 M 36 Y 6 std NA NO YES NA 2 DAYS YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
193 1790/ 15 M 29 N 4 std NA NO YES NA NA NO YES HETERO YES NO NO NO NO NO NO YES NR NR  
194 1707/ 15 M 44 N 3 std NA NO YES NA NA NO YES HETERO NO NO NO NO NO NO NO YES NR NR  
195 1699/ 15 M 24 N 5 std NA NO YES NA NA NO YES HETERO NO NO NO NO NO NO NO YES NR NR  
196 1696/ 15 M 34 Y 2 std NA NO YES NA 1 WEEK  YES NO HETERO NO NO NO NO NO NO NO YES NR NR  
197 1670/ 15 M 40 Y 10  std NA NO YES NA 4 DAYS YES NO HETERO NO IVD NO NO NO NO NO YES NR NR  
198 1671/ 15 M 40 Y 8 std NA NO YES NA 2 DAYS YES NO HETERO NO IVD NO NO NO NO NO YES NR NR  
199 209/ 15 M 41 Y 4 std NA NO YES NA 2 DAYS YES NO HETERO NO NO YES NO NO NO NO YES NR NR  
200 1682/ 15 M 30 Y 3 std NA NO YES NA 1 DAY YES NO HETERO NO NO NO NO NO NO NO YES REACTIV
E 
NR  
 
  
Key to Master Chart 
Sl. No- Serial number 
FSW- Female sex worker 
MSM- Men having sex with men 
Prom. M- Promiscuous men 
Prom. W- Promiscuous women 
TG- Transgender 
Hetero- Heterosexual 
Ano- anal 
Oro- Oral 
Rec- Receptive 
Ins- Insertive 
Bisex-Bisexual 
Prot. Sex- Protected sex 
EMC- Extra marital contact 
PMC- Premarital contact 
LMC- Last Marital contact 
Asso. Disease- Associated Sexually Transmitted Illnesses 
  
IVD- IV drug abuse 
Blood trans- Transfusion 
Endo cer- Endocervical 
URe- Urethral 
Rect- Rectal 
Hi.VAG- High vaginal 
Phary- Pharyngeal 
RPR- Rapid Plasma Reagin 
HIV- Human Immunodeficiency virus  
HPV PCR- Human Papilloma Virus Polymerase Chain Reaction 
NA-Not applicable 
NR- Non Reactive 
 
 
